Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Pichler Martin |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2023

Originalarbeit (Zeitschrift)

** Lindenmann, J; Fediuk, M; Fink-Neuboeck, N; Mykoliuk, I; Taucher, E; Pichler, M; Smolle, J; Smolle-Juettner, FM The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung Cancer.
Cells. 2023; 12(3): Doi: 10.3390/cells12030480 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Helmberg, W; Matzhold, EM; Barth, DA; Sareban, N; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M Impact of allogeneic red blood cell transfusion on prognosis in soft tissue sarcoma patients. A single-centre study.
Cancer Med. 2023; 12(2):1237-1246 Doi: 10.1002/cam4.4989 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Originalarbeit (Zeitschrift)

** Barth, DA; Stanzer, S; Spiegelberg, J; Bauernhofer, T; Absenger, G; Posch, F; Lipp, R; Halm, M; Szkandera, J; Balic, M; Gerger, A; Smolle, MA; Hutterer, GC; Klec, C; Jost, PJ; Kargl, J; Stradner, M; Pichler, M Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Cancer Med. 2022; 11(16):3074-3083 Doi: 10.1002/cam4.4675 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Stanzer, S; Spiegelberg, JA; Bauernhofer, T; Absenger, G; Szkandera, J; Gerger, A; Smolle, MA; Hutterer, GC; Ahyai, SA; Madl, T; Posch, F; Riedl, JM; Klec, C; Jost, PJ; Kargl, J; Stradner, MH; Pichler, M Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Front Immunol. 2022; 13: 840207 Doi: 10.3389/fimmu.2022.840207 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Dieckmann, KP; Pokrivcak, T; Geczi, L; Niehaus, D; Dralle-Filiz, I; Matthies, C; Dienes, T; Zschabitz, S; Paffenholz, P; Gschliesser, T; Pichler, R; Mego, M; Bader, P; Zengerling, F; Heinzelbecker, J; Krausewitz, P; Krege, S; Aurilio, G; Aksoy, C; Hentrich, M; Seidel, C; Torzsok, P; Nestler, T; Majewski, M; Hiester, A; Buchler, T; Vallet, S; Studentova, H; Schonburg, S; Niedersuss-Beke, D; Ring, J; Trenti, E; Heidenreich, A; Wulfing, C; Isbarn, H; Pichlmeier, U; Pichler, M Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
THER ADV MED ONCOL. 2022; 14: 17588359221086813 Doi: 10.1177/17588359221086813 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Fluhrer, H; Hutterer, GC; Golbeck, S; Stidl, M; Niedrist, T; Pichler, R; Mischinger, J; Seles, M; Mannweiler, S; Spiegelberg, J; Bauernhofer, T; Jost, PJ; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Ther Adv Med Oncol. 2022; 14: 17588359221134065 Doi: 10.1177/17588359221134065 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

** Juracek, J; Madrzyk, M; Stanik, M; Ruckova, M; Trachtova, K; Malcikova, H; Lzicarova, E; Barth, DA; Pichler, M; Slaby, O A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer
PROSTATE. 2022; Doi: 10.1002/pros.24466
Web of Science PubMed FullText FullText_MUG

 

** Klec, C; Knutsen, E; Schwarzenbacher, D; Jonas, K; Pasculli, B; Heitzer, E; Rinner, B; Krajina, K; Prinz, F; Gottschalk, B; Ulz, P; Deutsch, A; Prokesch, A; Jahn, SW; Lellahi, SM; Perander, M; Barbano, R; Graier, WF; Parrella, P; Calin, GA; Pichler, M ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.
Cell Mol Life Sci. 2022; 79(7): 391 Doi: 10.1007/s00018-022-04402-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Krstic, J; Reinisch, I; Schindlmaier, K; Galhuber, M; Riahi, Z; Berger, N; Kupper, N; Moyschewitz, E; Auer, M; Michenthaler, H; Nössing, C; Depaoli, MR; Ramadani-Muja, J; Usluer, S; Stryeck, S; Pichler, M; Rinner, B; Deutsch, AJA; Reinisch, A; Madl, T; Chiozzi, RZ; Heck, AJR; Huch, M; Malli, R; Prokesch, A Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism.
Sci Adv. 2022; 8(3):eabh2635 Doi: 10.1126/sciadv.abh2635 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Maisel, F; Smolle, MA; Mollnar, S; Riedl, JM; Barth, DA; Seles, M; Terbuch, A; Rossmann, CH; Eisner, F; Mannweiler, S; Hutterer, G; Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Jost, PJ; Bauernhofer, T; Pichler, M; Posch, F Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Clin Genitourin Cancer. 2022; 20(4):344-353 Doi: 10.1016/j.clgc.2022.03.010
Web of Science PubMed FullText FullText_MUG

 

** Mischinger, J; Schöllnast, H; Zurl, H; Geyer, M; Fischereder, K; Adelsmayr, G; Igrec, J; Fritz, G; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Trimmel, V; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, GP; Pichler, M; Riedl, J; Schöpfer-Schwab, S; Strobl, J; Hutterer, GC; Zigeuner, R; Pummer, K; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Front Surg. 2022; 9: 1013389 Doi: 10.3389/fsurg.2022.1013389 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Niedrist, T; Glantschnig, T; Firla, S; Moik, F; Kolesnik, E; Wallner, M; Verheyen, N; Jost, PJ; Zirlik, A; Pichler, M; Balic, M; Rainer, PP Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer.
Front Cardiovasc Med. 2022; 9: 933428 Doi: 10.3389/fcvm.2022.933428 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pototschnig, I; Feiler, U; Diwoky, C; Vesely, PW; Rauchenwald, T; Paar, M; Bakiri, L; Pajed, L; Hofer, P; Kashofer, K; Sukhbaatar, N; Schoiswohl, G; Weichhart, T; Hoefler, G; Bock, C; Pichler, M; Wagner, EF; Zechner, R; Schweiger, M Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia
J CACHEXIA SARCOPENI. 2022; Doi: 10.1002/jcsm.13109 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Prinz, F; Jonas, K; Balihodzic, A; Klec, C; Reicher, A; Barth, DA; Riedl, J; Gerger, A; Kiesslich, T; Mayr, C; Rinner, B; Kargl, J; Pichler, M MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response.
RNA Biol. 2022; 19(1):1305-1315 Doi: 10.1080/15476286.2022.2152978 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Schwarzenbacher, E; Moik, F; Horvath, L; Gantschnigg, A; Renneberg, F; Posch, F; Barth, DA; Stotz, M; Pichler, M; Hatzl, S; Fandler-Höfler, S; Gressenberger, P; Gary, T; Jost, PJ; Greil, R; Ay, C; Djanani, A; Gerger, A; Schlick, K Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Thromb Haemost. 2022; 122(4):633-645 Doi: 10.1055/a-1548-4847
Web of Science PubMed FullText FullText_MUG

 

** Uhl, B; Prochazka, KT; Pansy, K; Wenzl, K; Strobl, J; Baumgartner, C; Szmyra, MM; Waha, JE; Wolf, A; Tomazic, PV; Steinbauer, E; Steinwender, M; Friedl, S; Weniger, M; Küppers, R; Pichler, M; Greinix, HT; Stary, G; Ramsay, AG; Apollonio, B; Feichtinger, J; Beham-Schmid, C; Neumeister, P; Deutsch, AJ Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.
Int J Mol Sci. 2022; 23(14): Doi: 10.3390/ijms23147874 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Balihodzic, A; Prinz, F; Dengler, MA; Calin, GA; Jost, PJ; Pichler, M Non-coding RNAs and ferroptosis: potential implications for cancer therapy.
Cell Death Differ. 2022; 29(6):1094-1106 Doi: 10.1038/s41418-022-00998-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hutterer, GC; Pichler, M Renal cell carcinoma-presentation highlights from the ESMO Congress 2021
MEMO-MAG EUR MED ONC. 2022; Doi: 10.1007/s12254-022-00798-6
Web of Science FullText FullText_MUG

 

Editorial

** Lindner, AK; Pichler, M; Thurnher, M; Pichler, R Targeting c-Met to Improve Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma.
Eur Urol. 2022; 81(1): 1-2. Doi: 10.1016/j.eururo.2021.10.025
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M Best of ASCO 2022-bladder cancer
MEMO-MAG EUR MED ONC. 2022; Doi: 10.1007/s12254-022-00847-0
Web of Science FullText FullText_MUG

 

Fallbericht

** Huemer, M; Jahn-Kuch, D; Hofmann, G; Pichler, M A case report of immediate effects of acupuncture on neuropathic cancer breakthrough pain.
Complement Ther Clin Pract. 2022; 48: 101599 Doi: 10.1016/j.ctcp.2022.101599
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Hochmair, M; Schmidinger, M; Ay, L; Robinson, I; Absenger, G; Pichler, M; Nguyen, VA; Richtig, E; Rainer, B; Jansen, C; Sladek, B; Knabl, A; Gasche, N; Valipour, A BiomeOne: multi-center Validation of a new microbiome-based Biomarker to predict Response to Cancer Immunotherapy
ONCOL RES TREAT. 2022; 45(SUPPL 2):229-229.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien. [Poster]
Web of Science

 

** Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien. [Poster]
Web of Science

 

** Robinson, I; Hochmair, MJ; Jansen, C; Pacifico, C; Sladek, B; Knabl, A; Gasche, N; Absenger, G; Pichler, M; Valipour, A Prediction of immune checkpoint inhibitor (ICI) response in non-small cell lung cancer (NSCLC) patients using a microbiome-based biomarker
WIEN KLIN WOCHENSCHR. 2022; 134(19-20): 742-742. [Poster]
Web of Science

 

** Robinson, I; Schmidinger, M; Hochmair, MJ; Ay, L; Absenger, G; Pichler, M; Nguyen, VAF; Richtig, E; Rainer, B; Jansen, C; Sladek, B; Knabl, A; Gasche, N; Valipour, A BiomeOne: Multi-centric validation of a novel microbiome-based biomarker to predict response to cancer immunotherapy
ANN ONCOL. 2022; 33(7):S592-S592.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); SEP 09-13, 2022; ELECTR NETWORK. Doi: 10.1016/j.annonc.2022.07.149 [Poster]
Web of Science FullText FullText_MUG

 

2021

Originalarbeit (Zeitschrift)

** Barth, DA; Sareban, N; Lindner, AK; Daller, LAJ; Matzhold, EM; Hutterer, G; Smolle, M; Mischinger, J; Riedl, JM; Seles, M; Mannweiler, S; Bauernhofer, T; Pummer, K; Pichler, R; Zigeuner, R; Schlenke, P; Pichler, M Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Urol Oncol. 2021; 39(10):736.e9-736.e16 Doi: 10.1016/j.urolonc.2021.06.005 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Berg, JL; Perfler, B; Hatzl, S; Mayer, MC; Wurm, S; Uhl, B; Reinisch, A; Klymiuk, I; Tierling, S; Pregartner, G; Bachmaier, G; Berghold, A; Geissler, K; Pichler, M; Hoefler, G; Strobl, H; Wölfler, A; Sill, H; Zebisch, A Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.
Clin Epigenetics. 2021; 13(1): 1-1. Doi: 10.1186/s13148-020-00979-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakić, E; Richtig, G; Richtig, E; Rohrer, PM; Koch, L; Wolf, IH; Koch, C; Rainer, BM; Koeller, M; Pichler, M; Gerritsmann, H; Kashofer, K; Aigelsreiter, A Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.
Cancers (Basel). 2021; 13(12): Doi: 10.3390/cancers13123101 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Huemer, M; Jahn-Kuch, D; Hofmann, G; Andritsch, E; Farkas, C; Schaupp, W; Masel, EK; Jost, PJ; Pichler, M Trends and Patterns in the Public Awareness of Palliative Care, Euthanasia, and End-of-Life Decisions in 3 Central European Countries Using Big Data Analysis From Google: Retrospective Analysis.
J Med Internet Res. 2021; 23(9): e28635 Doi: 10.2196/28635 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Laprovitera, N; Riefolo, M; Porcellini, E; Durante, G; Garajova, I; Vasuri, F; Aigelsreiter, A; Dandachi, N; Benvenuto, G; Agostinis, F; Sabbioni, S; Berindan, Neagoe, I; Romualdi, C; Ardizzoni, A; Trerè, D; Pichler, M; D'Errico, A; Ferracin, M MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Mol Oncol. 2021; 15(10):2732-2751 Doi: 10.1002/1878-0261.13026 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mollnar, S; Pondorfer, P; Kasparek, AK; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Terbuch, A; Eisner, F; Gerger, A; Kapp, KS; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Stöger, H; Thurnher, D; Posch, F Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
Clin Transl Oncol. 2021; 23(3):543-553 Doi: 10.1007/s12094-020-02447-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Müller, M; Posch, F; Kiem, D; Barth, D; Horvath, L; Stotz, M; Schaberl-Moser, R; Pichler, M; Greil, R; Jost, PJ; Seeber, A; Amann, A; Schlick, K; Gerger, A; Riedl, JM Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Ther Adv Med Oncol. 2021; 13: 17588359211039930 Doi: 10.1177/17588359211039930 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, M; Steyrer, J Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1.
ESMO Open. 2021; 6(4): 100198 Doi: 10.1016/j.esmoop.2021.100198 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Prinz, F; Balihodzic, A; Mayr, C; Kiesslich, T; Klec, C; Jonas, K; Barth, DA; Riedl, JM; Gerger, A; Pichler, M MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.
Cancers (Basel). 2021; 13(16): Doi: 10.3390/cancers13163996 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Hasenleithner, SO; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stöger, H; Berghold, A; Hoefler, G; Speicher, MR; Heitzer, E; Gerger, A Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Ther Adv Med Oncol. 2021; 13:1758835920987658 Doi: 10.1177/1758835920987658 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, DA; Rossmann, CH; Stotz, M; Schaberl-Moser, R; Pichler, M; Stöger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Eur J Cancer. 2021; 151: 3-13. Doi: 10.1016/j.ejca.2021.03.040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stoeger, H; Leithner, A; Heitzer, E; Liegl-Atzwanger, B; Szkandera, J Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Ther Adv Med Oncol. 2021; 13:17588359211029125 Doi: 10.1177/17588359211029125 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Scheipner, L; Smolle, MA; Barth, D; Posch, F; Stotz, M; Pichler, M; StÖger, H; Gerger, A; Riedl, JM The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Anticancer Res. 2021; 41(1):429-436 Doi: 10.21873/anticanres.14792
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Herbsthofer, L; Goda, M; Granegger, B; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; El-Heliebi, A; Pichler, M; Gerger, A; Posch, F; Tomberger, M; López-García, P; Feichtinger, J; Baumgartner, C; Leithner, A; Liegl-Atzwanger, B; Szkandera, J Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma.
Oncoimmunology. 2021; 10(1):1896658-1896658 Doi: 10.1080/2162402X.2021.1896658 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Herbsthofer, L; Granegger, B; Goda, M; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; Pichler, M; Gerger, A; Rossmann, C; Riedl, J; Tomberger, M; López-García, P; El-Heliebi, A; Leithner, A; Liegl-Atzwanger, B; Szkandera, J T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study.
Br J Cancer. 2021; 125(5):717-724 Doi: 10.1038/s41416-021-01456-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Tulchiner, G; Staudacher, N; Fritz, J; Hackl, M; Pichler, M; Seles, M; Shariat, SF; D'Andrea, D; Gust, K; Albrecht, W; Grubmüller, K; Madersbacher, S; Graf, S; Lusuardi, L; Augustin, H; Berger, A; Loidl, W; Horninger, W; Pichler, R Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria.
Cancers (Basel). 2021; 13(21): Doi: 10.3390/cancers13215377 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Valadez-Cosmes, P; Maitz, K; Kindler, O; Raftopoulou, S; Kienzl, M; Santiso, A; Mihalic, ZN; Brcic, L; Lindenmann, J; Fediuk, M; Pichler, M; Schicho, R; Houghton, AM; Heinemann, A; Kargl, J Identification of Novel Low-Density Neutrophil Markers Through Unbiased High-Dimensional Flow Cytometry Screening in Non-Small Cell Lung Cancer Patients.
Front Immunol. 2021; 12: 703846 Doi: 10.3389/fimmu.2021.703846 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Balihodzic, A; Barth, DA; Prinz, F; Pichler, M Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer.
Cancers (Basel). 2021; 13(5): 977 Doi: 10.3390/cancers13050977 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Ghafouri-Fard, S; Shoorei, H; Abak, A; Abbas Raza, SH; Pichler, M; Taheri, M Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment.
Biomed Pharmacother. 2020; 134: 111172-111172. Doi: 10.1016/j.biopha.2020.111172 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Laprovitera, N; Riefolo, M; Ambrosini, E; Klec, C; Pichler, M; Ferracin, M Cancer of Unknown Primary: Challenges and Progress in Clinical Management.
Cancers (Basel). 2021; 13(3): Doi: 10.3390/cancers13030451 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, E; Taucher, V; Lindenmann, J; Jost, PJ; Pichler, M Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer.
Cancers (Basel). 2021; 13(4): Doi: 10.3390/cancers13040699 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, E; Taucher, V; Lindenmann, J; Pichler, M; Smolle-Juettner, FM Liquid biopsy in non-small cell lung cancer-current status and future outlook-a narrative review.
Transl Lung Cancer Res. 2021; 10(5): 2237-2251. Doi: 10.21037/tlcr-21-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Taheri, M; Barth, DA; Kargl, J; Rezaei, O; Ghafouri-Fard, S; Pichler, M Emerging Role of Non-Coding RNAs in Regulation of T-Lymphocyte Function.
Front Immunol. 2021; 12: 756042 Doi: 10.3389/fimmu.2021.756042 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Pichler, M MicroRNAs, precision oncology and innovative diagnostics in testicular germ cell tumor patients - an update
ONCOL RES TREAT. 2021; 44: 17-17.
Web of Science

 

2020

Originalarbeit (Zeitschrift)

** Alkan, HF; Vesely, PW; Hackl, H; Foßelteder, J; Schmidt, DR; Vander Heiden, MG; Pichler, M; Hoefler, G; Bogner-Strauss, JG Deficiency of malate-aspartate shuttle component SLC25A12 induces pulmonary metastasis.
Cancer Metab. 2020; 8(1):26-26 Doi: 10.1186/s40170-020-00232-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Brenner, C; Riedl, JM; Prinz, F; Klocker, EV; Schlick, K; Kornprat, P; Lackner, K; Stöger, H; Stotz, M; Gerger, A; Pichler, M External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
Cancer Med. 2020; 9(15):5473-5479 Doi: 10.1002/cam4.3233 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Greinix, H; Pichler, M; Neumeister, P; Prochazka, KT Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
Hematol Oncol. 2020; 38(3):277-283 Doi: 10.1002/hon.2727 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klocker, EV; Barth, DA; Riedl, JM; Prinz, F; Szkandera, J; Schlick, K; Kornprat, P; Lackner, K; Lindenmann, J; Stöger, H; Stotz, M; Gerger, A; Pichler, M Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Cancers (Basel). 2020; 12(5): Doi: 10.3390/cancers12051154 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219 Doi: 10.1038/s41598-020-68010-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Knittelfelder, O; Delago, D; Jakse, G; Lukasiak, K; Thurner, EM; Thurnher, D; Pichler, M; Renner, W; Stranzl-Lawatsch, H; Langsenlehner, T The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy.
Cancers (Basel). 2020; 12(3): 626 Doi: 10.3390/cancers12030626 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lindenmann, J; Fediuk, M; Fink-Neuboeck, N; Porubsky, C; Pichler, M; Brcic, L; Anegg, U; Balic, M; Dandachi, N; Maier, A; Smolle, M; Smolle, J; Smolle-Juettner, FM Hazard Curves for Tumor Recurrence and Tumor-Related Death Following Esophagectomy for Esophageal Cancer.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082066 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lindenmann, J; Fink-Neuboeck, N; Taucher, V; Pichler, M; Posch, F; Brcic, L; Smolle, E; Koter, S; Smolle, J; Smolle-Juettner, FM Prediction of Postoperative Clinical Outcomes in Resected Stage I Non-Small Cell Lung Cancer Focusing on the Preoperative Glasgow Prognostic Score.
Cancers (Basel). 2020; 12(1): Doi: 10.3390/cancers12010152 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moritz, J; Bauernhofer, T; Mannweiler, S; Langsenlehner, T; Pummer, K; Dandachi, N; Pichler, M Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer Patients.
In Vivo. 2020; 34(6): 3631-3638. Doi: 10.21873/invivo.12209 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, M; Rodriguez-Aguayo, C; Nam, SY; Dragomir, MP; Bayraktar, R; Anfossi, S; Knutsen, E; Ivan, C; Fuentes-Mattei, E; Lee, SK; Ling, H; Catela Ivkovic, T; Huang, G; Huang, L; Okugawa, Y; Katayama, H; Taguchi, A; Bayraktar, E; Bhattacharya, R; Amero, P; He, WR; Tran, AM; Vychytilova-Faltejskova, P; Klec, C; Bonilla, DL; Zhang, X; Kapitanovic, S; Loncar, B; Gafà, R; Wang, Z; Cristini, V; Hanash, SM; Bar-Eli, M; Lanza, G; Slaby, O; Goel, A; Rigoutsos, I; Lopez-Berestein, G; Calin, GA Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.
Gut. 2020; 69(10): 1818-1831. Doi: 10.1136/gutjnl-2019-318903 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Reicher, A; Harris, AL; Prinz, F; Kiesslich, T; Wei, M; Öllinger, R; Rad, R; Pichler, M; Kwong, LN Generation of An Endogenous FGFR2-BICC1 Gene Fusion/58 Megabase Inversion Using Single-Plasmid CRISPR/Cas9 Editing in Biliary Cells.
Int J Mol Sci. 2020; 21(7): 2460 Doi: 10.3390/ijms21072460 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Barth, DA; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoeger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Posch, F C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082319 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Seles, M; Hutterer, GC; Foßelteder, J; Svoboda, M; Resel, M; Barth, DA; Pichler, R; Bauernhofer, T; Zigeuner, RE; Pummer, K; Slaby, O; Klec, C; Pichler, M Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
Cancers (Basel). 2020; 12(5): 1200 Doi: 10.3390/cancers12051200 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smith, CG; Moser, T; Mouliere, F; Field-Rayner, J; Eldridge, M; Riediger, AL; Chandrananda, D; Heider, K; Wan, JCM; Warren, AY; Morris, J; Hudecova, I; Cooper, WN; Mitchell, TJ; Gale, D; Ruiz-Valdepenas, A; Klatte, T; Ursprung, S; Sala, E; Riddick, ACP; Aho, TF; Armitage, JN; Perakis, S; Pichler, M; Seles, M; Wcislo, G; Welsh, SJ; Matakidou, A; Eisen, T; Massie, CE; Rosenfeld, N; Heitzer, E; Stewart, GD Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Genome Med. 2020; 12(1): 23-23. Doi: 10.1186/s13073-020-00723-8 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Sande, MV; Callegaro, D; Wunder, J; Hayes, A; Leitner, L; Bergovec, M; Tunn, PU; van Praag, V; Fiocco, M; Panotopoulos, J; Willegger, M; Windhager, R; Dijkstra, SPD; van Houdt, WJ; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Andreou, D; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models.
Cancers (Basel). 2019; 12(1): Doi: 10.3390/cancers12010047 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stelzl, A; Aziz, F; Riedl, JM; Posch, F; Smolle, MA; Stojakovic, T; Terbuch, A; Pichler, M; Bergovec, M; Leithner, A; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Sourij, H; Szkandera, J Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients.
Sci Rep. 2020; 10(1): 12438-12438. Doi: 10.1038/s41598-020-69237-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Barth, DA; Riedl, JM; Asamer, E; Klocker, EV; Kornprat, P; Hutterer, GC; Prinz, F; Lackner, K; Stöger, H; Gerger, A; Pichler, M The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer.
Cancers (Basel). 2020; 12(7): Doi: 10.3390/cancers12071798 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** van Manen, L; Groen, JV; Putter, H; Pichler, M; Vahrmeijer, AL; Bonsing, BA; Mieog, JSD Stage-Specific Value of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Serum Levels on Survival and Recurrence in Pancreatic Cancer: A Single Center Study and Meta-Analysis.
Cancers (Basel). 2020; 12(10): 2970 Doi: 10.3390/cancers12102970 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Zhou, Q; Perakis, SO; Ulz, P; Mohan, S; Riedl, JM; Talakic, E; Lax, S; Tötsch, M; Hoefler, G; Bauernhofer, T; Pichler, M; Gerger, A; Geigl, JB; Heitzer, E; Speicher, MR Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer.
Genome Med. 2020; 12(1):20 Doi: 10.1186/s13073-020-0719-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Hatzl, S; Posch, F; Schulz, E; Gornicec, M; Deutsch, A; Beham-Schmid, C; Pichler, M; Greinix, H; Sill, H; Zebisch, A; Neumeister, P; Prochazka, KT The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
Pathol Oncol Res. 2020; 26(4):2831-2833 Doi: 10.1007/s12253-020-00864-6
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Barth, DA; Drula, R; Ott, L; Fabris, L; Slaby, O; Calin, GA; Pichler, M Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers.
Front Cell Dev Biol. 2020; 8:828 Doi: 10.3389/fcell.2020.00828 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Juracek, J; Slaby, O; Pichler, M; Calin, GA lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082148 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Prinz, F; Teppan, J; Jonas, K; Klec, C; Pichler, M Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer.
Noncoding RNA. 2020; 6(3): Doi: 10.3390/ncrna6030027 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Bekric, D; Neureiter, D; Ritter, M; Jakab, M; Gaisberger, M; Pichler, M; Kiesslich, T; Mayr, C Long Non-Coding RNAs in Biliary Tract Cancer-An Up-to-Date Review.
J Clin Med. 2020; 9(4): 1200 Doi: 10.3390/jcm9041200 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Henzinger, H; Barth, DA; Klec, C; Pichler, M Non-Coding RNAs and SARS-Related Coronaviruses.
Viruses. 2020; 12(12): Doi: 10.3390/v12121374 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hsieh, PL; Liao, YW; Pichler, M; Yu, CC MicroRNAs as Theranostics Targets in Oral Carcinoma Stem Cells.
Cancers (Basel). 2020; 12(2): 340 Doi: 10.3390/cancers12020340 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Jonas, K; Calin, GA; Pichler, M RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer.
Int J Mol Sci. 2020; 21(8): Doi: 10.3390/ijms21082969 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Regouc, M; Belge, G; Lorch, A; Dieckmann, KP; Pichler, M Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer.
Cancers (Basel). 2020; 12(3): 749 Doi: 10.3390/cancers12030749 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Teppan, J; Barth, DA; Prinz, F; Jonas, K; Pichler, M; Klec, C Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor Angiogenesis.
Noncoding RNA. 2020; 6(4): Doi: 10.3390/ncrna6040042 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fallbericht

** Lembeck, AL; Puchas, P; Hutterer, G; Barth, DA; Terbuch, A; Bauernhofer, T; Pichler, M MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients.
Noncoding RNA. 2020; 6(1): Doi: 10.3390/ncrna6010002 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bauernhofer, T; Stanzer, S; Prietl, B; Kofler, S; Obermayer-Pietsch, B; Pichler, M; Sourij, H; Pieber, T Tregs cells - a double edged sword? Lessons learned from colorectal cancer in comparison to type 1 diabetes mellitus.
ONCOL RES TREAT. 2020; 43(SUPPL 4):127-128. [Poster]
Web of Science

 

** Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakic, E; Richtig, G; Richtig, E; Rohrer, P; Koch, L; Wolf, I; Koch, C; Rainer, B; Koeller, M; Pichler, M; Kashofer, K; Aigelsreiter, A Feasibility and first results of circulating tumor DNA as a marker for treatment response in metastatic melanoma patients using Next Generation Sequencing.
ONCOL RES TREAT. 2020; 43(SUPPL 4):166-167. [Onlinepräsentation]
Web of Science

 

** Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.1331 [Onlinepräsentation] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Klec, C; Kapeller, A; Prinz, F; Trenk, C; Stoger, H; Pichler, M Dissecting the interplay of the long non-coding RNA NORAD and PARP inhibitors in triple negative breast cancer.
CANCER RES. 2020; 80(4):-San Antonio Breast Cancer Symposium; DEC 10-14, 2019; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS19-P1-05-13 [Poster]
Web of Science FullText FullText_MUG

 

** Klec, C; Schwarzenbacher, D; Gottschalk, B; Margit, R; Prinz, F; Bauernhofer, T; Stoeger, H; Graier, WF; Pichler, M Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism.
ANN ONCOL. ESMO Breast Cancer Virtual Meeting 2020. 2020; 31(S2):S38-S38.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.03.202 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Laprovitera, N; Porcellini, E; Riefolo, M; Broseghini, E; Garajova, I; Sabbioni, S; Pichler, M; Ardizzoni, A; D'Errico, A; Ferracin, M Cancer of unknown primary site-of-origin: An enigma ready to be miR-solved
CANCER RES. Abstracts. 2020; 80(16):-AACR Annual Meeting; JUN 22-24, 2020; Virtuell. Doi: 10.1158/1538-7445.AM2020-5432 [Poster]
Web of Science FullText FullText_MUG

 

** Posch, F; Barth, D; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Riedl, JM C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study.
ANN ONCOL. 2020; 31: S286-S286.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.234 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress). [Oral Communication]
Web of Science

 

** Riedl, J; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Schaberl-Moser, R; Stotz, M; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: An Austrian observational Tri-Center comparative effectiveness analysis.
ONCOL RES TREAT. 2020; 43(SUPPL 4):215-215. [Poster]
Web of Science

 

** Riedl, JM; Posch, F; Gantschnigg, A; Horvath, L; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nabPaclitaxel as First-line palliative Therapy in advanced Pancreatic Cancer: a Propensity-Score Analysis.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):78-79.-51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
ANN ONCOL. 2020; 31: S942-S942.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2013 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Schwarzenbacher, E; Moik, F; Horvath, L; Renneberg, F; Posch, F; Barth, D; Gantschnigg, A; Schaberl-Moser, R; Pichler, M; Stotz, M; Stoger, H; Ay, C; Greil, R; Gerger, A; Djanani, A; Schlick, K; Riedl, J Incidence, prediction and outcome of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of Gemcitabine/nab-Paclitxel or FOLFIRINOX.
ONCOL RES TREAT. 2020; 43(SUPPL 4):214-214. [Poster]
Web of Science

 

** Schwarzenbacher, E; Moik, F; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Ay, C; Stoger, H; Greil, R; Djanani, A; Gerger, A; Schlick, K; Riedl, JM Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX.
ANN ONCOL. 2020; 31: S949-S950.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2035 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

2019

Originalarbeit (Zeitschrift)

** Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043 Doi: 10.1007/s12094-019-02037-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Dieckmann, KP; Radtke, A; Geczi, L; Matthies, C; Anheuser, P; Eckardt, U; Sommer, J; Zengerling, F; Trenti, E; Pichler, R; Belz, H; Zastrow, S; Winter, A; Melchior, S; Hammel, J; Kranz, J; Bolten, M; Krege, S; Haben, B; Loidl, W; Ruf, CG; Heinzelbecker, J; Heidenreich, A; Cremers, JF; Oing, C; Hermanns, T; Fankhauser, CD; Gillessen, S; Reichegger, H; Cathomas, R; Pichler, M; Hentrich, M; Eredics, K; Lorch, A; Wülfing, C; Peine, S; Wosniok, W; Bokemeyer, C; Belge, G Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
J Clin Oncol. 2019; 37(16): 1412-1423. Doi: 10.1200/JCO.18.01480 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hutterer, GC; Posch, F; Buser, L; Zigeuner, R; Morshäuser, L; Otto, W; Wild, PJ; Burger, M; May, M; Pichler, M; Brookman-May, SD BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Urol Oncol. 2019; 37(7): 510-518. Doi: 10.1016/j.urolonc.2019.04.004
Web of Science PubMed FullText FullText_MUG

 

** Klec, C; Gutschner, T; Panzitt, K; Pichler, M Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention.
Expert Opin Ther Targets. 2019; 23(3): 177-186. Doi: 10.1080/14728222.2019.1570499
Web of Science PubMed FullText FullText_MUG

 

** Lembeck, AL; Posch, F; Klocker, EV; Szkandera, J; Schlick, K; Stojakovic, T; Kornprat, P; Lackner, C; Gerger, A; Stoeger, H; Stotz, M; Pichler, M Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Clin Chem Lab Med. 2019; 57(5):740-744 Doi: 10.1515/cclm-2018-0016
Web of Science PubMed FullText FullText_MUG

 

** Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Fuchs, J; Pichler, M; Ritter, M; Jakab, M; Helm, K; Neureiter, D; Kiesslich, T Continuous, label-free, 96-well-based determination of cell migration using confluence measurement.
Cell Adh Migr. 2019; 13(1):76-82 Doi: 10.1080/19336918.2018.1526612 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548 Doi: 10.1038/s41598-019-42069-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, R; Compérat, E; Klatte, T; Pichler, M; Loidl, W; Lusuardi, L; Schmidinger, M Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
Cancers (Basel). 2019; 11(3): 422 Doi: 10.3390/cancers11030422 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Aigelsreiter, AM; Asslaber, M; Weiland, T; Pichler, M; Eberhard, K; Sygulla, S; Schauer, S; Hoefler, G; Aigelsreiter, A Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma.
Histopathology. 2019; 75(1):118-127 Doi: 10.1111/his.13860 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schlick, K; Magnes, T; Huemer, F; Ratzinger, L; Weiss, L; Pichler, M; Melchardt, T; Greil, R; Egle, A C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.
J Clin Med. 2019; 8(11): Doi: 10.3390/jcm8111791 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schwarzenbacher, D; Klec, C; Pasculli, B; Cerk, S; Rinner, B; Karbiener, M; Ivan, C; Barbano, R; Ling, H; Wulf-Goldenberg, A; Stanzer, S; Rinnerthaler, G; Stoeger, H; Bauernhofer, T; Haybaeck, J; Hoefler, G; Jahn, SW; Parrella, P; Calin, GA; Pichler, M MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Breast Cancer Res. 2019; 21(1): 20-20. Doi: 10.1186/s13058-019-1104-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; van Praag, VM; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Riedl, JM; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Fiocco, M; van de Sande, MA; Leithner, A Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methods.
Eur J Surg Oncol. 2019; 45(2):242-248 Doi: 10.1016/j.ejso.2018.06.019
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596 Doi: 10.21873/anticanres.13753
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Barth, DA; Slaby, O; Klec, C; Juracek, J; Drula, R; Calin, GA; Pichler, M Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.
Cancers (Basel). 2019; 11(10): Doi: 10.3390/cancers11101580 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hutterer, GC; Pichler, M Advanced/metastatic urothelial carcinoma of the bladder and upper urinary tract Presentation highlights from the ASCO 2019 Congress
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00532-9
Web of Science FullText FullText_MUG

 

** Klec, C; Prinz, F; Pichler, M Involvement of the long noncoding RNA NEAT1 in carcinogenesis.
Mol Oncol. 2019; 13(1):46-60 Doi: 10.1002/1878-0261.12404 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klec, C; Ziomek, G; Pichler, M; Malli, R; Graier, WF Calcium Signaling in ß-cell Physiology and Pathology: A Revisit.
Int J Mol Sci. 2019; 20(24): Doi: 10.3390/ijms20246110 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Prinz, F; Kapeller, A; Pichler, M; Klec, C The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases.
Int J Mol Sci. 2019; 20(3): Doi: 10.3390/ijms20030627 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, E; Fink-Neuboeck, N; Lindenmann, J; Smolle-Juettner, F; Pichler, M The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer.
Cancers (Basel). 2019; 11(8): Doi: 10.3390/cancers11081118 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, E; Pichler, M Non-Smoking-Associated Lung Cancer: A distinct Entity in Terms of Tumor Biology, Patient Characteristics and Impact of Hereditary Cancer Predisposition.
Cancers (Basel). 2019; 11(2): Doi: 10.3390/cancers11020204 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Prinz, F; Calin, GA; Pichler, M Current concepts of non-coding RNA regulation of immune checkpoints in cancer.
Mol Aspects Med. 2019; 70:117-126 Doi: 10.1016/j.mam.2019.09.007
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Xiao, H; Shiu, PKT; Gabryleska, M; Conn, SJ; Dey, A; Chakrabarti, K; Regouc, M; Pichler, M; Ørom, UAV; Santulli, G; Nishiwada, S; Goel, A; Nagarajan, V; Timmons, L; Alahari, SK; Laprovitera, N; Ferracin, M; Hu, P; Jin, H The Non-Coding RNA Journal Club: Highlights on Recent Papers-7.
Noncoding RNA. 2019; 5(2): 40 Doi: 10.3390/ncrna5020040 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477. [Poster]
Web of Science

 

** Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Barth, DA; Riedl, JM; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 108-108. [Poster]
Web of Science

 

** Glantschnig, T; Posch, F; Firla, S; Moik, F; Ablasser, K; Binder, JS; Stoschitzky, G; Wallner, M; Von Lewinski, D; Stoger, H; Zirlik, A; Pichler, M; Rainer, PP Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
WIEN KLIN WOCHENSCHR. 2019; 131: 292-293. [Poster]
Web of Science

 

** Krstic, J; Reinisch, I; Depaoli, M; Berger, N; Noessing, C; Galhuber, M; Anders, I; Auer, M; Moyschewitz, E; Rinner, B; Pichler, M; Malli, R; Prokesch, A Overcoming sorafenib resistance in hepatocellular carcinoma by fasting
BRIT J CANCER. 2019; 121: 16-17. [Oral Communication]
Web of Science FullText

 

** Posch, F; Glantschnig, T; Firla, S; Smolle, M; Balic, M; Moik, F; Stoeger, H; Zirlik, A; Pichler, M; Rainer, P Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
EUR HEART J. 2019; 40: 3844-3844.-ESC Congress / World Congress of Cardiology; AUG 31-SEP 04, 2019; Paris, FRANCE. [Poster]
Web of Science

 

** Riedl, JM; Barth, D; Posch, F; Foris, V; Absenger, G; Mollnar, S; Pichler, M; Stotz, M; Stoger, H; Olschewski, H; Gerger, A Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 115-115. [Poster]
Web of Science

 

** Riedl, JM; Barth, DA; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T; Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA. [Poster]
Web of Science FullText

 

2018

Originalarbeit (Zeitschrift)

** Al-Zoughbi, W; Schauer, S; Pichler, M; Hoefler, G Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma.
Pathobiology. 2018; 85(5-6): 342-347. Doi: 10.1159/000492433 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Asamer, E; Szkandera, J; Gibiser, P; Lembeck, AL; Stojakovic, T; Kornprat, P; Lackner, C; Winder, T; Schlick, K; Stöger, H; Gerger, A; Pichler, M; Stotz, M Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Wien Klin Wochenschr. 2018; 130(19-20):569-574 Doi: 10.1007/s00508-018-1383-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Del Vecchio, F; Lee, GH; Hawezi, J; Bhome, R; Pugh, S; Sayan, E; Thomas, G; Packham, G; Primrose, J; Pichler, M; Mirnezami, A; Calin, G; Bullock, M Long non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk.
Cancer Lett. 2018; 421: 94-102. Doi: 10.1016/j.canlet.2018.02.022 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival.
Sci Rep. 2018; 8(1):14528-14528 Doi: 10.1038/s41598-018-32972-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Foßelteder, J; Calin, GA; Pichler, M Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancer.
Expert Opin Ther Targets. 2018; 22(12):973-976 Doi: 10.1080/14728222.2018.1541453 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Krassnig, S; Wodlej, C; Brcic, L; Lindenmann, J; Fink-Neuboeck, N; Gollowitsch, F; Stacher-Priehse, E; Asslaber, M; Gogg-Kamerer, M; Rolff, J; Hoffmann, J; Silvestri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Sokolova, O; Naumann, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.
Eur J Cancer. 2018; 101(4):165-180 Doi: 10.1016/j.ejca.2018.07.001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gutschner, T; Richtig, G; Haemmerle, M; Pichler, M From biomarkers to therapeutic targets-the promises and perils of long non-coding RNAs in cancer.
Cancer Metastasis Rev. 2018; 37(1):83-105 Doi: 10.1007/s10555-017-9718-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hasenoehrl, C; Feuersinger, D; Sturm, EM; Bärnthaler, T; Heitzer, E; Graf, R; Grill, M; Pichler, M; Beck, S; Butcher, L; Thomas, D; Ferreirós, N; Schuligoi, R; Schweiger, C; Haybaeck, J; Schicho, R G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.
Int J Cancer. 2018; 142(1):121-132 Doi: 10.1002/ijc.31030 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Pichler, M; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T Miniaturization of the Clonogenic Assay Using Confluence Measurement.
Int J Mol Sci. 2018; 19(3): Doi: 10.3390/ijms19030724 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mayr, C; Helm, K; Jakab, M; Ritter, M; Shrestha, R; Makaju, R; Wagner, A; Pichler, M; Beyreis, M; Staettner, S; Jaeger, T; Klieser, E; Kiesslich, T; Neureiter, D The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
Hum Pathol. 2018; 72:117-126 Doi: 10.1016/j.humpath.2017.11.003
Web of Science PubMed FullText FullText_MUG

 

** Morshaeuser, L; May, M; Burger, M; Otto, W; Hutterer, GC; Pichler, M; Klatte, T; Wild, P; Buser, L; Brookman-May, S p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
Urol Oncol. 2018; 36(3):94.e15-94.e94 Doi: 10.1016/j.urolonc.2017.11.011
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Partl, R; Döller, C; Riedl, JM; Smolle, M; Leitner, L; Bergovec, M; Liegl-Atzwanger, B; Stotz, M; Bezan, A; Gerger, A; Pichler, M; Kapp, KS; Stöger, H; Leithner, A; Szkandera, J Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.
Ann Surg Oncol. 2018; 25(3):776-783 Doi: 10.1245/s10434-017-6080-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Silina, K; Leibl, S; Mündlein, A; Moch, H; Siebenhüner, A; Samaras, P; Riedl, J; Stotz, M; Szkandera, J; Stöger, H; Pichler, M; Stupp, R; van den Broek, M; Schraml, P; Gerger, A; Petrausch, U; Winder, T Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.
Oncoimmunology. 2018; 7(2):e1378844-e1378844 Doi: 10.1080/2162402X.2017.1378844 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Reicher, A; Foßelteder, J; Kwong, LN; Pichler, M Crosstalk between the Notch signaling pathway and long non-coding RNAs.
Cancer Lett. 2018; 420: 91-96. Doi: 10.1016/j.canlet.2018.01.070
Web of Science PubMed FullText FullText_MUG

 

** Richtig, G; Hoeller, C; Wolf, M; Wolf, I; Rainer, BM; Schulter, G; Richtig, M; Grübler, MR; Gappmayer, A; Haidn, T; Kofler, J; Huegel, R; Lange-Asschenfeldt, B; Pichler, M; Pilz, S; Heinemann, A; Richtig, E Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study.
PLoS One. 2018; 13(10):e0204729-e0204729 Doi: 10.1371/journal.pone.0204729 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schneider, C; Wallner, M; Kolesnik, E; Herbst, V; Mächler, H; Pichler, M; von Lewinski, D; Sedej, S; Rainer, PP The Anti-Cancer Multikinase Inhibitor Sorafenib Impairs Cardiac Contractility by Reducing Phospholamban Phosphorylation and Sarcoplasmic Calcium Transients.
Sci Rep. 2018; 8(1):5295-5295 Doi: 10.1038/s41598-018-23630-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Shen, P; Reineke, LC; Knutsen, E; Chen, M; Pichler, M; Ling, H; Calin, GA Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling.
Mol Oncol. 2018; 12(11): 1856-1870. Doi: 10.1002/1878-0261.12384 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Adiprasito, JB; Stiegelbauer, V; Seles, M; Klec, C; Pichler, GP; Resel, M; Posch, F; Lembeck, AL; Stöger, H; Szkandera, J; Pummer, K; Bauernhofer, T; Hutterer, GC; Gerger, A; Stotz, M; Pichler, M MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Int J Mol Sci. 2018; 19(10): Doi: 10.3390/ijms19103130 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 Doi: 10.1002/cam4.1317 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Prochazka, KT; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Abdyli, L; Greinix, H; Pichler, M; Neumeister, P Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.
Br J Haematol. 2018; 183(1):142-146 Doi: 10.1111/bjh.14912 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Küppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, AJA; Haybaeck, J Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome.
Blood Cancer J. 2018; 8(9): 79-79. Doi: 10.1038/s41408-018-0112-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83. [Poster]
Web of Science

 

** Koeller, M; Berger, M; Eder, S; Richtig, G; Richtig, E; Pichler, M; Winter, G; Hoefler, G; Aigelsreiter, A. Is microsatellite-instability a prognostic factor in melanoma patients treated with immune-checkpoint inhibitors?
VIRCHOWS ARCH. 2018; 473: S9-S10. [Oral Communication]
Web of Science

 

** Leithner, A; van Praag, V; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Juttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stoger, H; Liegl-Atzwanger, B; Smolle, MA Efficacy of metastasectomy on survival in patients with metachronous soft tissue sarcoma-metastasis: Results of a bi-centre study including 135 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY. [Poster]
Web of Science

 

** Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248. [Poster]
Web of Science

 

** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J Translation initiation factors are over-expressed in aggressive lymphomas and influence their clinical course
ONCOL RES TREAT. 2018; 41: 164-164. [Poster]
Web of Science

 

Abstract (Konferenzband)

** Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F Estimated versus measured glomerular filtration rate to evaluate kidney function in patients with cancer undergoing cisplatin-based chemotherapy
Oncology Research and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Poster]
Web of Science FullText

 

** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T Lymphopenia impairs response to 1st-line therapy with sunitinib and pazopanib in patients with metastatic clear-cell renal cell carcinoma.
Oncology Research and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Oral Communication]
Web of Science FullText

 

Kommentar

** Pichler, R; Loidl, W; Pichler, M High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer.
Transl Androl Urol. 2018; 7(Suppl 6):S738-S740 Doi: 10.21037/tau.2018.08.15 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, E; Pichler, M Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer-the more specific, the better?
J Thorac Dis. 2018; 10(Suppl 33):S3961-S3964 Doi: 10.21037/jtd.2018.09.81 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Originalarbeit (Zeitschrift)

** Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Douschan, P; Rainer, F; Stauber, R; Haybaeck, J; Denk, H; Lackner, C Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.
Liver Int. 2017; 37(4):600-610 Doi: 10.1111/liv.13325
Web of Science PubMed FullText FullText_MUG

 

** Bayraktar, R; Pichler, M; Kanlikilicer, P; Ivan, C; Bayraktar, E; Kahraman, N; Aslan, B; Oguztuzun, S; Ulasli, M; Arslan, A; Calin, G; Lopez-Berestein, G; Ozpolat, B MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
Oncotarget. 2017; 8(7): 11641-11658. Doi: 10.18632/oncotarget.14264 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
PLoS One. 2017; 12(4):e0176283-e0176283 Doi: 10.1371/journal.pone.0176283 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Dalpiaz, O; Krieger, D; Ehrlich, GC; Pohlmann, K; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M; Hutterer, GC Validation of the Preoperative Platelet-to-Lymphocyte Ratio as a Prognostic Factor in a European Cohort of Patients with Upper Tract Urothelial Carcinoma.
Urol Int. 2017; 98(3):320-327 Doi: 10.1159/000452109
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Luef, T; Seles, M; Stotz, M; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Br J Cancer. 2017; 116(1):85-90 Doi: 10.1038/bjc.2016.393 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Deutsch, AJA; Rinner, B; Pichler, M; Prochazka, K; Pansy, K; Bischof, M; Fechter, K; Hatzl, S; Feichtinger, J; Wenzl, K; Frisch, MT; Stiegelbauer, V; Prokesch, A; Krogsdam, A; Sill, H; Thallinger, GG; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Cancer Res. 2017; 77(9):2375-2386 Doi: 10.1158/0008-5472.CAN-16-2320 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kessler, SM; Lederer, E; Laggai, S; Golob-Schwarzl, N; Hosseini, K; Petzold, J; Schweiger, C; Reihs, R; Keil, M; Hoffmann, J; Mayr, C; Kiesslich, T; Pichler, M; Kim, KS; Rhee, H; Park, YN; Lax, S; Obrist, P; Kiemer, AK; Haybaeck, J IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.
Oncotarget. 2017; 8(52):89736-89745 Doi: 10.18632/oncotarget.21116 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lindenmann, J; Fink-Neuboeck, N; Avian, A; Pichler, M; Habitzruther, M; Maier, A; Smolle-Juettner, FM Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Eur J Surg Oncol. 2017; 43(2):445-453 Doi: 10.1016/j.ejso.2016.10.015
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Stiegelbauer, V; Vychytilova-Faltejskova, P; Ivan, C; Ling, H; Winter, E; Zhang, X; Goblirsch, M; Wulf-Goldenberg, A; Ohtsuka, M; Haybaeck, J; Svoboda, M; Okugawa, Y; Gerger, A; Hoefler, G; Goel, A; Slaby, O; Calin, GA Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.
Clin Cancer Res. 2017; 23(5):1323-1333 Doi: 10.1158/1078-0432.CCR-16-0497 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Leitner, L; Bergovec, M; Bezan, A; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Leithner, A; Szkandera, J Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Clin Orthop Relat Res. 2017; 475(5):1427-1435 Doi: 10.1007/s11999-017-5232-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Rashed, MH; Kanlikilicer, P; Rodriguez-Aguayo, C; Pichler, M; Bayraktar, R; Bayraktar, E; Ivan, C; Filant, J; Silva, A; Aslan, B; Denizli, M; Mitra, R; Ozpolat, B; Calin, GA; Sood, AK; Abd-Ellah, MF; Helal, GK; Berestein, GL Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs.
Oncotarget. 2017; 8(12):20145-20164 Doi: 10.18632/oncotarget.15525 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Aigelsreiter, A; Schwarzenbacher, D; Ress, AL; Adiprasito, JB; Stiegelbauer, V; Hoefler, G; Schauer, S; Kiesslich, T; Kornprat, P; Winder, T; Eisner, F; Gerger, A; Stoeger, H; Stauber, R; Lackner, C; Pichler, M SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
PLoS One. 2017; 12(11):e0187814-e0187814 Doi: 10.1371/journal.pone.0187814 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Bezan, A; Szkandera, J; Smolle, MA; Winder, T; Rossmann, CH; Schaberl-Moser, R; Pichler, M; Stotz, M; Stöger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
BMC Cancer. 2017; 17(1):415-415 Doi: 10.1186/s12885-017-3392-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Moik, F; Bezan, A; Szkandera, J; Smolle, MA; Kasparek, AK; Pichler, M; Stöger, H; Stotz, M; Gerger, A Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting.
Oncotarget. 2017; 8(56):96048-96061 Doi: 10.18632/oncotarget.21647 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Rigoutsos, I; Lee, SK; Nam, SY; Anfossi, S; Pasculli, B; Pichler, M; Jing, Y; Rodriguez-Aguayo, C; Telonis, AG; Rossi, S; Ivan, C; Catela Ivkovic, T; Fabris, L; Clark, PM; Ling, H; Shimizu, M; Redis, RS; Shah, MY; Zhang, X; Okugawa, Y; Jung, EJ; Tsirigos, A; Huang, L; Ferdin, J; Gafà, R; Spizzo, R; Nicoloso, MS; Paranjape, AN; Shariati, M; Tiron, A; Yeh, JJ; Teruel-Montoya, R; Xiao, L; Melo, SA; Menter, D; Jiang, ZQ; Flores, ER; Negrini, M; Goel, A; Bar-Eli, M; Mani, SA; Liu, CG; Lopez-Berestein, G; Berindan-Neagoe, I; Esteller, M; Kopetz, S; Lanza, G; Calin, GA N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration.
Genome Biol. 2017; 18(1):98-98 Doi: 10.1186/s13059-017-1224-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Seeber, A; Gastl, G; Eisterer, W; Gampenrieder, SP; Gerger, A; Kieler, M; Pichler, M; Prager, GW; Untergasser, G; Weltermann, A; Greil, R The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling
MEMO-MAG EUR MED ONC. 2017; 10(4): 255-258. Doi: 10.1007/s12254-017-0369-6
Web of Science FullText FullText_MUG

 

** Seles, M; Posch, F; Pichler, GP; Gary, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.
J Urol. 2017; 198(6):1247-1252 Doi: 10.1016/j.juro.2017.07.036
Web of Science PubMed FullText FullText_MUG

 

** Stiegelbauer, V; Vychytilova-Faltejskova, P; Karbiener, M; Pehserl, AM; Reicher, A; Resel, M; Heitzer, E; Ivan, C; Bullock, M; Ling, H; Deutsch, A; Wulf-Goldenberg, A; Adiprasito, JB; Stoeger, H; Haybaeck, J; Svoboda, M; Stotz, M; Hoefler, G; Slaby, O; Calin, GA; Gerger, A; Pichler, M miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5.
Clin Cancer Res. 2017; 23(17):5255-5266 Doi: 10.1158/1078-0432.CCR-17-0023 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Herzog, SA; Pichler, M; Smolle, M; Riedl, J; Rossmann, C; Bezan, A; Stöger, H; Renner, W; Berghold, A; Gerger, A Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Anticancer Res. 2017; 37(4):2011-2018 Doi: 10.21873/anticanres.11545 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Posch, F; Annerer, LM; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Long-term cardiovascular complications in stage I seminoma patients.
Clin Transl Oncol. 2017; 19(11):1400-1408 Doi: 10.1007/s12094-017-1742-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Wallner, M; Khafaga, M; Kolesnik, E; Vafiadis, A; Schwantzer, G; Eaton, DM; Curcic, P; Köstenberger, M; Knez, I; Rainer, PP; Pichler, M; Pieske, B; Lewinski, DV Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium.
Oncotarget. 2017; 8(30):49264-49274 Doi: 10.18632/oncotarget.17540 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Woitas, RP; Scharnagl, H; Kleber, ME; Delgado, GE; Grammer, TB; Pichler, M; Krämer, BK; März, W; Stojakovic, T Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study-Impact for mortality.
PLoS One. 2017; 12(2):e0171574-e0171574 Doi: 10.1371/journal.pone.0171574 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Richtig, G; Richtig, E; Kashofer, K; Koch, L; Winter, G; Hoefler, G; Pichler, M; Ehall, B; Grübler, MR; Heinemann, A; Aigelsreiter, A Testing and clinical implications for non-V600 BRAF mutations in metastatic NRASmt melanoma.
Br J Dermatol. 2017; 177(3):860-861 Doi: 10.1111/bjd.15222
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Cătană, CS; Pichler, M; Giannelli, G; Mader, RM; Berindan-Neagoe, I Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma.
Oncotarget. 2017; 8(17):29519-29534 Doi: 10.18632/oncotarget.15706 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Goblirsch, M; Richtig, G; Slaby, O; Berindan-Neagoe, I; Gerger, A; Pichler, M MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.
Pharmacogenomics. 2017; 18(10):1027-1038 Doi: 10.2217/pgs-2017-0004
Web of Science PubMed FullText FullText_MUG

 

** Mayr, C; Ocker, M; Ritter, M; Pichler, M; Neureiter, D; Kiesslich, T Biliary tract cancer stem cells - translational options and challenges.
World J Gastroenterol. 2017; 23(14):2470-2482 Doi: 10.3748/wjg.v23.i14.2470 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Ehall, B; Richtig, E; Aigelsreiter, A; Gutschner, T; Pichler, M Function and Clinical Implications of Long Non-Coding RNAs in Melanoma.
Int J Mol Sci. 2017; 18(4): Doi: 10.3390/ijms18040715 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Hoeller, C; Kashofer, K; Aigelsreiter, A; Heinemann, A; Kwong, LN; Pichler, M; Richtig, E Beyond the BRAFV600E hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients.
Br J Dermatol. 2017; 177(4):936-944 Doi: 10.1111/bjd.15436
Web of Science PubMed FullText FullText_MUG

 

** Schanza, LM; Seles, M; Stotz, M; Fosselteder, J; Hutterer, GC; Pichler, M; Stiegelbauer, V MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Int J Mol Sci. 2017; 18(11): Doi: 10.3390/ijms18112495 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Shen, P; Pichler, M; Chen, M; Calin, GA; Ling, H To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer.
Int J Mol Sci. 2017; 18(9): Doi: 10.3390/ijms18092003 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Bauernhofer, T; Pummer, K; Calin, GA; Pichler, M Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Int J Mol Sci. 2017; 18(2): Doi: 10.3390/ijms18020473 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Calin, HN; Pichler, M; Calin, GA Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.
FEBS J. 2017; 284(13):1952-1966 Doi: 10.1111/febs.14030 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Leithner, A; Posch, F; Szkandera, J; Liegl-Atzwanger, B; Pichler, M MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.
Int J Mol Sci. 2017; 18(9): Doi: 10.3390/ijms18091960 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Editorial

** Smolle, MA; Pichler, M Inflammation, phagocytosis and cancer: another step in the CD47 act.
J Thorac Dis. 2017; 9(8): 2279-2282. Doi: 10.21037/jtd.2017.07.38 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL. Doi: 10.1200/JCO.2017.35.15_suppl.e16038 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Gogg-Kammerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Silvestri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J Eukaryotic translation initiation factors impact non small cell lung cancer
VIRCHOWS ARCH. 2017; 471: S104-S104. [Poster]
Web of Science

 

** Lindenmann, J; Fink-Neubock, N; Porubsky, C; Fediuk, M; Gschwandtner, E; Striessnig, A; Pichler, M; Brcic, L; Maier, A; Anegg, U; Smolle-Juttner, FM The clinical impact of the Glasgow Prognostic Score as additional independent prognostic parameter for patients with malignant pleural mesothelioma
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):774-774.-41. Jahrestagung der Österreichischen Gesellschaft für Pneumologie 1. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie; OCT 5-7, 2017; Innsbruck, AUSTRIA. [Poster]
Web of Science

 

** Lindenmann, J; Fink-Neubock, N; Porubsky, C; Fediuk, M; Gschwandtner, E; Striessnig, A; Swatek, P; Pichler, M; Stacher-Priehse, E; Anegg, U; Maier, A; Smolle-Juttner, FM How long should we follow up operated patients with stage I non-small cell lung cancer (NSCLC)?
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):772-772.-41. Jahrestagung der Österreichischen Gesellschaft für Pneumologie- 1. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie; OCT 5-7, 2017; Innsbruck, AUSTRIA. [Poster]
Web of Science

 

** Mayr, C; Wagner, A; Loffelberger, M; Bruckner, D; Jakab, M; Berr, F; Fazio, P; Ocker, M; Neureiters, D; Pichler, M; Kiesslich, T The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in binary tract cancer cells
ACTA PHYSIOL. 2017; 221: 250-252. [Poster]
Web of Science

 

** Unterluggauer, J; Beham-Schmid, C; Tomazic, PV; Fechter, K; Rinner, B; Pichler, M; Weniger, M; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Deutsch, A; Haybaeck, J Translation initiation factors as novel prognostic biomarkers of aggressive B-cell lymphomas
VIRCHOWS ARCH. 2017; 471: S43-S43. [Poster]
Web of Science

 

Kommentar

** Posch, F; Pichler, M Inflammatory Biomarkers in Diffuse Large B-Cell Lymphoma: Time for Extending the Established Prognosis Scores?
Acta Haematol. 2017; 137(2):73-75 Doi: 10.1159/000455020
Web of Science PubMed FullText FullText_MUG

 

** Richtig, G; Pichler, M Prediction of Response in Melanoma Therapy by Systemic Inflammatory Response - One Size Fits Not All.
EBioMedicine. 2017; 18(6):13-14 Doi: 10.1016/j.ebiom.2017.03.032 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Richtig, G; Aigelsreiter, AM; Sygulla, S; Schauer, S; Asslaber, M; Pichler, M; Höfler, G; Aigelsreiter, A Hedgehog pathway proteins SMO and GLI expression in head and neck squamous cell carcinoma – a potential therapeutic target?.
Virchows Arch. 2017; 471: S152-S152.-29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, The Netherlands. [Poster]
Web of Science FullText

 

2016

Originalarbeit (Zeitschrift)

** Al-Zoughbi, W; Pichler, M; Gorkiewicz, G; Guertl-Lackner, B; Haybaeck, J; Jahn, SW; Lackner, C; Liegl-Atzwanger, B; Popper, H; Schauer, S; Nusshold, E; Kindt, AS; Trajanoski, Z; Speicher, MR; Haemmerle, G; Zimmermann, R; Zechner, R; Vesely, PW; Hoefler, G Loss of adipose triglyceride lipase is associated with human cancer and induces mouse pulmonary neoplasia.
Oncotarget. 2016; 7(23):33832-33840 Doi: 10.18632/oncotarget.9418 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Belaj, K; Pichler, M; Hackl, G; Rief, P; Eller, P; Hafner, F; Brodmann, M; Gary, T Association of the Derived Neutrophil-Lymphocyte Ratio With Critical Limb Ischemia.
Angiology. 2016; 67(4):350-354 Doi: 10.1177/0003319715590701
Web of Science PubMed FullText FullText_MUG

 

** Bonin, S; Donada, M; Bussolati, G; Nardon, E; Annaratone, L; Pichler, M; Chiaravalli, AM; Capella, C; Hoefler, G; Stanta, G A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.
Tumour Biol. 2016; 37(6):7295-7303 Doi: 10.1007/s13277-015-4543-3
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Geiger, O; Kuepper, MK; Caraffini, V; Seime, T; Furlan, T; Nussbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Quehenberger, F; Wölfler, A; Troppmair, J; Sill, H; Zebisch, A Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.
Cancer Res. 2016; 76(12):3644-3654 Doi: 10.1158/0008-5472.CAN-15-3049 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kammerer, S; Jahn, SW; Winter, E; Eidenhammer, S; Rezania, S; Regitnig, P; Pichler, M; Schreibmayer, W; Bauernhofer, T Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry.
J Clin Pathol. 2016; 69(12):1116-1121 Doi: 10.1136/jclinpath-2016-203798 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, SW; El-Heliebi, A; Schwarzenbacher, D; Stiegelbauer, V; Pichler, M; Rezania, S; Fiegl, H; Peintinger, F; Regitnig, P; Hoefler, G; Schreibmayer, W; Bauernhofer, T KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
Oncotarget. 2016; 7(51):84705-84717 Doi: 10.18632/oncotarget.13224 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kanlikilicer, P; Rashed, MH; Bayraktar, R; Mitra, R; Ivan, C; Aslan, B; Zhang, X; Filant, J; Silva, AM; Rodriguez-Aguayo, C; Bayraktar, E; Pichler, M; Ozpolat, B; Calin, GA; Sood, AK; Lopez-Berestein, G Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells.
Cancer Res. 2016; 76(24):7194-7207 Doi: 10.1158/0008-5472.CAN-16-0714 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
Tumour Biol. 2016; 37(1):361-368 Doi: 10.1007/s13277-015-3805-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ling, H; Pickard, K; Ivan, C; Isella, C; Ikuo, M; Mitter, R; Spizzo, R; Bullock, M; Braicu, C; Pileczki, V; Vincent, K; Pichler, M; Stiegelbauer, V; Hoefler, G; Almeida, MI; Hsiao, A; Zhang, X; Primrose, J; Packham, G; Liu, K; Bojja, K; Gafà, R; Xiao, L; Rossi, S; Song, JH; Vannini, I; Fanini, F; Kopetz, S; Zweidler-McKay, P; Wang, X; Ionescu, C; Irimie, A; Fabbri, M; Lanza, G; Hamilton, SR; Berindan-Neagoe, I; Medico, E; Mirnezami, A; Calin, GA; Nicoloso, MS The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
Gut. 2016; 65(6):977-989 Doi: 10.1136/gutjnl-2015-309372 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mayr, C; Wagner, A; Loeffelberger, M; Bruckner, D; Jakab, M; Berr, F; Di Fazio, P; Ocker, M; Neureiter, D; Pichler, M; Kiesslich, T The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
Oncotarget. 2016; 7(1):745-758 Doi: 10.18632/oncotarget.6378 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Ohtsuka, M; Ling, H; Ivan, C; Pichler, M; Matsushita, D; Goblirsch, M; Stiegelbauer, V; Shigeyasu, K; Zhang, X; Chen, M; Vidhu, F; Bartholomeusz, GA; Toiyama, Y; Kusunoki, M; Doki, Y; Mori, M; Song, S; Gunther, JR; Krishnan, S; Slaby, O; Goel, A; Ajani, JA; Radovich, M; Calin, GA H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer.
EBioMedicine. 2016; 13(3):113-124 Doi: 10.1016/j.ebiom.2016.10.026 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pehserl, AM; Ress, AL; Stanzer, S; Resel, M; Karbiener, M; Stadelmeyer, E; Stiegelbauer, V; Gerger, A; Mayr, C; Scheideler, M; Hutterer, GC; Bauernhofer, T; Kiesslich, T; Pichler, M Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122011 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer. 2016; 115(10):1264-1272 Doi: 10.1038/bjc.2016.325 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Rief, P; Pichler, M; Raggam, R; Hafner, F; Gerger, A; Eller, P; Brodmann, M; Gary, T The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
Medicine (Baltimore). 2016; 95(24):e3843-e3843 Doi: 10.1097/MD.0000000000003843 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Liegl-Atzwanger, B; Posch, F; Mrsic, E; Thalhammer, M; Stojakovic, T; Bezan, A; Pichler, M; Gerger, A; Szkandera, J Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
PLoS One. 2016; 11(7):e0159448-e0159448 Doi: 10.1371/journal.pone.0159448 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
J Clin Pathol. 2016; 69(4):326-330 Doi: 10.1136/jclinpath-2015-203356
Web of Science PubMed FullText FullText_MUG

 

** Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Nat Commun. 2016; 7(15):12008-12008 Doi: 10.1038/ncomms12008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Urbas, R; Mayr, C; Klieser, E; Fuereder, J; Bach, D; Stättner, S; Primavesi, F; Jaeger, T; Stanzer, S; Ress, AL; Löffelberger, M; Wagner, A; Berr, F; Ritter, M; Pichler, M; Neureiter, D; Kiesslich, T Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122053 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Gilg, MM; Berghold, A; Hutterer, GC; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Sci Rep. 2016; 6(4):33551-33551 Doi: 10.1038/srep33551 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Cerk, S; Schwarzenbacher, D; Adiprasito, JB; Stotz, M; Hutterer, GC; Gerger, A; Ling, H; Calin, GA; Pichler, M Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Int J Mol Sci. 2016; 17(9): Doi: 10.3390/ijms17091485 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Ling, H; Krassnig, L; Bullock, MD; Pichler, M MicroRNAs in Testicular Cancer Diagnosis and Prognosis.
Urol Clin North Am. 2016; 43(1):127-134 Doi: 10.1016/j.ucl.2015.08.013
Web of Science PubMed FullText FullText_MUG

 

** Mayr, C; Beyreis, M; Wagner, A; Pichler, M; Neureiter, D; Kiesslich, T Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.
Biomed Res Int. 2016; 2016(12):4805270-4805270 Doi: 10.1155/2016/4805270 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Perakis, SO; Thomas, JE; Pichler, M Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Adv Exp Med Biol. 2016; 937(4):183-204 Doi: 10.1007/978-3-319-42059-2_10
Web of Science PubMed FullText FullText_MUG

 

** Seles, M; Hutterer, GC; Kiesslich, T; Pummer, K; Berindan-Neagoe, I; Perakis, S; Schwarzenbacher, D; Stotz, M; Gerger, A; Pichler, M Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Int J Mol Sci. 2016; 17(4):573-573 Doi: 10.3390/ijms17040573 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Zebisch, A; Hatzl, S; Pichler, M; Wölfler, A; Sill, H Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122080 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, CG; Beham-Schmid, C; Neumeister, P; NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1.
BLOOD. BLOOD128: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 03-06, 2016) Doi: 10.1182/blood.V128.22.2728.2728
Web of Science FullText FullText_MUG

 

** Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.107 [Poster]
Web of Science FullText FullText_MUG

 

** Schneider, C; Wallner, M; Abdellatif, M; von Lewinski, D; Pichler, M; Sedej, S; Rainer, P The anti-cancer tyrosine kinase inhibitor sorafenib reduces cardiac contractile force by reducing cardiomyocyte calcium transient amplitude
WIEN KLIN WOCHENSCHR. 2016; 128: S309-S310. [Poster]
Web of Science

 

** Smolle, MA; Flick, H; Pichler, M; Olschewski, H; Lindenmann, J; Gerger, A Is it safe to use NSAIDs for pain control during chemical pleurodesis for malignant pleural effusion?
WIEN KLIN WOCHENSCHR. .. 2016; 128(19-20):772-773. [Poster]
Web of Science

 

** Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw371.77 [Poster]
Web of Science FullText FullText_MUG

 

** Woitas, R; Scharnagl, H; Kleber, ME; Delgado, GE; Grammer, TB; Pichler, M; Kramer, BK; Marz, W; Stojakovic, T IMPACT OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AND NEUTROPHIL COUNTS IN THE LUDWIGSHAFEN RISK AND CARDIOVASCULART HEALTH STUDY
ATHEROSCLEROSIS. 2016; 252: E67-E67.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. Doi: 10.1016/j.atherosclerosis.2016.07.455 [Poster]
Web of Science FullText FullText_MUG

 

2015

Originalarbeit (Zeitschrift)

** Bezan, A; Mrsic, E; Krieger, D; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
J Urol. 2015; 194(1):30-35 Doi: 10.1016/j.juro.2015.01.083
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Pichler, M; Mrsic, E; Reitz, D; Krieger, D; Venturino, L; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
J Clin Pathol. 2015; 68(7):547-551 Doi: 10.1136/jclinpath-2014-202683
Web of Science PubMed FullText FullText_MUG

 

** Gary, T; Pichler, M; Schilcher, G; Hafner, F; Hackl, G; Rief, P; Eller, P; Brodmann, M Elevated Blood Urea Nitrogen is Associated With Critical Limb Ischemia in Peripheral Arterial Disease Patients.
Medicine (Baltimore). 2015; 94(24):e948-e948 Doi: 10.1097/MD.0000000000000948 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hutterer, GC; Krieger, D; Mrsic, E; Pohlmann, K; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.
Anticancer Res. 2015; 35(6):3463-3469
Web of Science PubMed

 

** Hutterer, GC; Sobolev, N; Ehrlich, GC; Gutschi, T; Stojakovic, T; Mannweiler, S; Pummer, K; Zigeuner, R; Pichler, M; Dalpiaz, O Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
J Clin Pathol. 2015; 68(5):351-355 Doi: 10.1136/jclinpath-2014-202658
Web of Science PubMed FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.
Breast. 2015; 24(5):667-672 Doi: 10.1016/j.breast.2015.08.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, T; Pichler, M; Thurner, EM; Krenn-Pilko, S; Stojakovic, T; Gerger, A; Langsenlehner, U Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy.
Urol Oncol. 2015; 33(5): 201.e9-201201. Doi: 10.1016/j.urolonc.2015.02.002
PubMed FullText FullText_MUG

 

** Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Gerger, A; Pichler, M Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
World J Urol. 2015; 33(11):1661-1667 Doi: 10.1007/s00345-015-1494-7
Web of Science PubMed FullText FullText_MUG

 

** Lindenmann, J; Fink-Neuboeck, N; Pichler, M; Anegg, U; Maier, A; Smolle, J; Smolle-Juettner, FM Stage-based treatment for thymoma in due consideration of thymectomy: a single-center experience and comparison with the literature.
World J Surg Oncol. 2015; 13(2):303-303 Doi: 10.1186/s12957-015-0718-z [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mayr, C; Neureiter, D; Pichler, M; Berr, F; Wagner, A; Kiesslich, T; Namberger, K Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.
Mol Med Rep. 2015; 12(2):2247-2252 Doi: 10.3892/mmr.2015.3589 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mayr, C; Wagner, A; Neureiter, D; Pichler, M; Jakab, M; Illig, R; Berr, F; Kiesslich, T The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
BMC Complement Altern Med. 2015; 15(6):194-194 Doi: 10.1186/s12906-015-0721-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mayr, C; Wagner, A; Stoecklinger, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T 3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer.
Anticancer Res. 2015; 35(9):4697-4705
Web of Science PubMed

 

** Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Hopfinger, G; Magnes, T; Deutsch, A; Neumeister, P; Hackl, H; Greil, R; Pichler, M; Egle, A A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.
Br J Haematol. 2015; 168(2):239-245 Doi: 10.1111/bjh.13116 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Schlick, K; Huemer, F; Deutsch, A; Neumeister, P; Greil, R; Pichler, M; Egle, A Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.
J Natl Compr Canc Netw. 2015; 13(12):1501-1508 Doi: 10.6004/jnccn.2015.0178 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Reitz, D; Gerger, A; Seidel, J; Kornprat, P; Samonigg, H; Stotz, M; Szkandera, J; Pichler, M Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.
J Clin Pathol. 2015; 68(6):427-433 Doi: 10.1136/jclinpath-2014-202451
Web of Science PubMed FullText FullText_MUG

 

** Ress, AL; Perakis, S; Pichler, M microRNAs and Colorectal Cancer.
Adv Exp Med Biol. 2015; 889(6):89-103 Doi: 10.1007/978-3-319-23730-5_6
Web of Science PubMed FullText FullText_MUG

 

** Ress, AL; Stiegelbauer, V; Winter, E; Schwarzenbacher, D; Kiesslich, T; Lax, S; Jahn, S; Deutsch, A; Bauernhofer, T; Ling, H; Samonigg, H; Gerger, A; Hoefler, G; Pichler, M MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
Mol Carcinog. 2015; 54(11):1442-1450 Doi: 10.1002/mc.22218
Web of Science PubMed FullText FullText_MUG

 

** Ress, AL; Wagle, R; Pichler, M Multi-omics in prognosis of hepatocellular carcinoma.
Ann Transl Med. 2015; 3(1):2-2 Doi: 10.3978/j.issn.2305-5839.2014.12.07 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schwarzenbacher, D; Stiegelbauer, V; Deutsch, A; Ress, AL; Aigelsreiter, A; Schauer, S; Wagner, K; Langsenlehner, T; Resel, M; Gerger, A; Ling, H; Ivan, C; Calin, GA; Hoefler, G; Rinner, B; Pichler, M Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Oncotarget. 2015; 6(13):11191-11202 Doi: 10.18632/oncotarget.3586 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Szkandera, J; Stojakovic, T; Seidel, J; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Seggewies, F; Hoefler, G; Gerger, A; Pichler, M The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Clin Chem Lab Med. 2015; 53(3):499-506 Doi: 10.1515/cclm-2014-0447
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Friesenbichler, J; Stojakovic, T; Leithner, A; Pichler, M The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.
Am J Surg. 2015; 210(1): 111-116. Doi: 10.1016/j.amjsurg.2014.10.021
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Gary, T; Leithner, A; Pichler, M Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients.
Clin Chem Lab Med. 2015; 53(3):493-497 Doi: 10.1515/cclm-2014-0486
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Herzog, S; Pichler, M; Stiegelbauer, V; Stotz, M; Schaberl-Moser, R; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Renner, W; Lenz, HJ; Berghold, A; Gerger, A LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
Pharmacogenomics J. 2015; 15(5):391-396 Doi: 10.1038/tpj.2015.2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
World J Urol. 2015; 33(10):1467-1473 Doi: 10.1007/s00345-014-1459-2
Web of Science PubMed FullText FullText_MUG

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Eur J Cancer. 2015; 51(5):610-619 Doi: 10.1016/j.ejca.2015.01.002
Web of Science PubMed FullText FullText_MUG

 

** Troppan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, GG; Beham-Schmid, C; Neumeister, P; Deutsch, A miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Int J Mol Sci. 2015; 16(8):18077-18095 Doi: 10.3390/ijms160818077 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Troppan, KT; Melchardt, T; Deutsch, A; Schlick, K; Stojakovic, T; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Egle, A; Pichler, M The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Eur J Haematol. 2015; 95(6):538-544 Doi: 10.1111/ejh.12529
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Bochis, OV; Irimie, A; Pichler, M; Berindan-Neagoe, I The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
J Gastrointestin Liver Dis. 2015; 24(2):225-234 Doi: 10.15403/jgld.2014.1121.242.skp2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ling, H; Vincent, K; Pichler, M; Fodde, R; Berindan-Neagoe, I; Slack, FJ; Calin, GA Junk DNA and the long non-coding RNA twist in cancer genetics.
Oncogene. 2015; 34(39):5003-5011 Doi: 10.1038/onc.2014.456 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mayr, C; Neureiter, D; Wagner, A; Pichler, M; Kiesslich, T The role of polycomb repressive complexes in biliary tract cancer.
Expert Opin Ther Targets. 2015; 19(3):363-375 Doi: 10.1517/14728222.2014.986460
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Calin, GA MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients.
Br J Cancer. 2015; 113(4):569-573 Doi: 10.1038/bjc.2015.253 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Bullock, MD; Ling, H; Pichler, M; Haybaeck, J Long Non-Coding RNAs in Endometrial Carcinoma.
Int J Mol Sci. 2015; 16(11):26463-26472 Doi: 10.3390/ijms161125962 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Pichler, M; Haybaeck, J; Gerger, A Genetic markers of recurrence in colorectal cancer.
Pharmacogenomics. 2015; 16(11):1315-1328 Doi: 10.2217/pgs.15.83
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Gerger, A; Haybaeck, J; Kiesslich, T; Bullock, MD; Pichler, M Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.
Anticancer Res. 2015; 35(11):5737-5744
Web of Science PubMed

 

** Thomas, J; Ohtsuka, M; Pichler, M; Ling, H MicroRNAs: Clinical Relevance in Colorectal Cancer.
Int J Mol Sci. 2015; 16(12):28063-28076 Doi: 10.3390/ijms161226080 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Editorial

** Wagle, R; Ohtsuka, M; Ling, H; Pichler, M RNA interference in the clinics: where are we standing now?
Future Oncol. 2015; 11(2):185-187 Doi: 10.2217/fon.14.243
Web of Science PubMed FullText FullText_MUG

 

Fallbericht

** Eisner, F; Pichler, M; Goletz, S; Stoeger, H; Samonigg, H A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options.
J Clin Pathol. 2015; 68(12):1044-1046 Doi: 10.1136/jclinpath-2015-202996 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gary, T; Pichler, M; Rief, P; Hafner, F; Brodmann, M The AST/ALT Ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease Patients
WIEN KLIN WOCHENSCHR. 2015; 127(17-18):721-721. [Poster]
Web of Science

 

** Hatzl, S; Geiger, O; Kuepper, MK; Seime, T; Nussbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Wolfler, A; Troppmair, J; Sill, H; Zebisch, A Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a
ONCOL RES TREAT. 2015; 38: 99-99. [Oral Communication]
Web of Science

 

** Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Jesche, J; Pummer, K; Zigeuner, R; Pichler, M Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy versus targeted agents): A European single-center experience over 26 years.
J CLIN ONCOL. 2015; 33(7):-Genitourinary Cancers Symposium; FEB 26-28, 2015; Orlando, FL. Doi: 10.1200/jco.2015.33.7_suppl.513 [Poster]
Web of Science FullText FullText_MUG

 

** Hutterer, GC; Golbeck, SV; Mrsic, E; Krieger, D; Bezan, A; Pummer, K; Zigeuner, R; Pichler, M Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy vs. targeted agents): A European single-center experience over 26 years
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL. Doi: 10.1200/jco.2015.33.15_suppl.e15617 [Poster]
Web of Science FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Thurner, E; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T An elevated preoperative plasma fibrinogen level is related with poor prognosis in breast cancer.
BREAST. 2015; 24: S104-S104.-14th St.Gallen International Breast Cancer Conference; MAR 18-21, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0960-9776(15)70261-4 [Poster]
Web of Science FullText FullText_MUG

 

** Mayr, C; Wagner, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest
ACTA PHYSIOL. 2015; 213: 148-148. [Poster]
Web of Science

 

** Mayr, C; Wagner, A; Stoecklinger, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T DZNep directly targets putative cancer stem cells in biliary tract cancer cells by inhibition of polycomb repressive complex 2
ACTA PHYSIOL. 2015; 213: 147-148. [Poster]
Web of Science

 

** Troopan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, G; Beham-Schmid, C; Neumeister, P; Deutsch, A MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in aggressive non-Hodgkin's lymphoma patients
ONCOL RES TREAT. 2015; 38: 63-64. [Poster]
Web of Science

 

2014

Originalarbeit (Zeitschrift)

** Absenger, G; Benhaim, L; Szkandera, J; Zhang, W; Yang, D; Labonte, MJ; Pichler, M; Stotz, M; Samonigg, H; Renner, W; Gerger, A; Lenz, HJ The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.
Pharmacogenomics J. 2014; 14(2):130-134 Doi: 10.1038/tpj.2013.15
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, AL; Koller, K; Salzwimmer, M; Gerger, A; Schauer, S; Bauernhofer, T; Pichler, M Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
Hum Pathol. 2014; 45(4):683-690 Doi: 10.1016/j.humpath.2013.11.014
Web of Science PubMed FullText FullText_MUG

 

** Aziz, A; May, M; Zigeuner, R; Pichler, M; Chromecki, T; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Hoschke, B; Gilfrich, C; Feciche, B; Fenske, F; Sountoulides, P; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Del Carmen Santiago Martin, M; Wieland, WF; Salzano, L; Lotrecchiano, G; Waidelich, R; Stief, C; Brookman-May, S; Members of the CORONA Project and the Young Academic Urologists Renal Cancer Group Do young patients with renal cell carcinoma feature a distinct outcome after surgery? A comparative analysis of patient age based on the multinational CORONA database.
J Urol. 2014; 191(2):310-315 Doi: 10.1016/j.juro.2013.08.021
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Ehrlich, GC; Mannweiler, S; Hernández, JM; Gerger, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M; Hutterer, GC Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
BJU Int. 2014; 114(3):334-339 Doi: 10.1111/bju.12441 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Pichler, M; Mannweiler, S; Martín Hernández, JM; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Br J Cancer. 2014; 110(10):2531-2536 Doi: 10.1038/bjc.2014.180 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Deutsch, AJ; Rinner, B; Wenzl, K; Pichler, M; Troppan, K; Steinbauer, E; Schwarzenbacher, D; Reitter, S; Feichtinger, J; Tierling, S; Prokesch, A; Scheideler, M; Krogsdam, A; Thallinger, GG; Schaider, H; Beham-Schmid, C; Neumeister, P NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.
Blood. 2014; 123(15):2367-2377 Doi: 10.1182/blood-2013-08-518878 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gary, T; Pichler, M; Belaj, K; Eller, P; Hafner, F; Gerger, A; Brodmann, M Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients.
Int J Clin Pract. 2014; 68(12):1483-1487 Doi: 10.1111/ijcp.12495
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Stoeckigt, C; Stojakovic, T; Jesche, J; Eberhard, K; Pummer, K; Zigeuner, R; Pichler, M Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
Urol Oncol. 2014; 32(7):1041-1048 Doi: 10.1016/j.urolonc.2014.04.001
Web of Science PubMed FullText FullText_MUG

 

** Kiesslich, T; Mayr, C; Wachter, J; Bach, D; Fuereder, J; Wagner, A; Alinger, B; Pichler, M; Di Fazio, P; Ocker, M; Berr, F; Neureiter, D Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer.
Mol Cell Biochem. 2014; 396(1-2):257-268 Doi: 10.1007/s11010-014-2161-9
Web of Science PubMed FullText FullText_MUG

 

** Koller, K; Pichler, M; Koch, K; Zandl, M; Stiegelbauer, V; Leuschner, I; Hoefler, G; Guertl, B Nephroblastomas show low expression of microR-204 and high expression of its target, the oncogenic transcription factor MEIS1.
Pediatr Dev Pathol. 2014; 17(3):169-175 Doi: 10.2350/13-01-1288-OA.1
Web of Science PubMed FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.
Br J Cancer. 2014; 110(10):2524-2530 Doi: 10.1038/bjc.2014.163 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lindenmann, J; Fink-Neuboeck, N; Koesslbacher, M; Pichler, M; Stojakovic, T; Roller, RE; Maier, A; Anegg, U; Smolle, J; Smolle-Juettner, FM The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment.
J Surg Oncol. 2014; 110(6):645-650 Doi: 10.1002/jso.23711
Web of Science PubMed FullText FullText_MUG

 

** May, M; Cindolo, L; Zigeuner, R; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Wolff, I; Feciche, B; Fenske, F; Pichler, M; Schips, L; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, Mdel C; Salzano, L; Lotrecchiano, G; Waidelich, R; Stief, C; Sountoulides, P; Brookman-May, S; Members of CORONA project; Young Academic Urologists Renal Cancer Group Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life.
Urol Oncol. 2014; 32(8):1252-1258 Doi: 10.1016/j.urolonc.2014.04.013
Web of Science PubMed FullText FullText_MUG

 

** Mohan, S; Heitzer, E; Ulz, P; Lafer, I; Lax, S; Auer, M; Pichler, M; Gerger, A; Eisner, F; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
PLoS Genet. 2014; 10(3):e1004271-e1004271 Doi: 10.1371/journal.pgen.1004271 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, M; Dalpiaz, O; Ehrlich, GC; Stojakovic, T; Martín Hernández, JM; Mannweiler, S; Pummer, K; Zigeuner, R; Hutterer, GC Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma.
J Urol. 2014; 191(4):920-925 Doi: 10.1016/j.juro.2013.10.073
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Ress, AL; Winter, E; Stiegelbauer, V; Karbiener, M; Schwarzenbacher, D; Scheideler, M; Ivan, C; Jahn, SW; Kiesslich, T; Gerger, A; Bauernhofer, T; Calin, GA; Hoefler, G MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
Br J Cancer. 2014; 110(6):1614-1621 Doi: 10.1038/bjc.2014.51 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, M; Winter, E; Ress, AL; Bauernhofer, T; Gerger, A; Kiesslich, T; Lax, S; Samonigg, H; Hoefler, G miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.
J Clin Pathol. 2014; 67(3):198-203 Doi: 10.1136/jclinpath-2013-201904
Web of Science PubMed FullText FullText_MUG

 

** Ress, AL; Stiegelbauer, V; Schwarzenbacher, D; Deutsch, A; Perakis, S; Ling, H; Ivan, C; Calin, GA; Rinner, B; Gerger, A; Pichler, M Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
Oncotarget. 2014; 5(18):8492-8502 Doi: 10.18632/oncotarget.2329 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Pichler, M; Absenger, G; Szkandera, J; Arminger, F; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer.
Br J Cancer. 2014; 110(2):435-440 Doi: 10.1038/bjc.2013.785 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Szkandera, J; Seidel, J; Stojakovic, T; Samonigg, H; Reitz, D; Gary, T; Kornprat, P; Schaberl-Moser, R; Hoefler, G; Gerger, A; Pichler, M Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.
PLoS One. 2014; 9(8):e104730-e104730 Doi: 10.1371/journal.pone.0104730 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Friesenbichler, J; Trajanoski, S; Stojakovic, T; Eberhard, K; Leithner, A; Pichler, M The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas.
Int J Cancer. 2014; 135(2):362-370 Doi: 10.1002/ijc.28677 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Leithner, A; Pichler, M Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.
PLoS One. 2014; 9(9):e107297-e107297 Doi: 10.1371/journal.pone.0107297 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Arminger, F; Weissmueller, M; Schaberl-Moser, R; Samonigg, H; Kornprat, P; Stojakovic, T; Avian, A; Gerger, A The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients.
Am J Surg. 2014; 208(2):210-214 Doi: 10.1016/j.amjsurg.2013.10.030
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.
Clin Cancer Res. 2014; 20(6):1687-1697 Doi: 10.1158/1078-0432.CCR-13-1517 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Eberhard, K; Leithner, A; Gerger, A The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
J Surg Oncol. 2014; 109(2):139-144 Doi: 10.1002/jso.23458
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Stotz, M; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Alzoughbi, W; Lackner, C; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.
Br J Cancer. 2014; 110(1):183-188 Doi: 10.1038/bjc.2013.701 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Troppan, K; Deutsch, A; Gerger, A; Stojakovic, T; Beham-Schmid, C; Wenzl, K; Neumeister, P; Pichler, M The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
Br J Cancer. 2014; 110(2):369-374 Doi: 10.1038/bjc.2013.763 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Troppan, KT; Schlick, K; Deutsch, A; Melchardt, T; Egle, A; Stojakovic, T; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Pichler, M C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Br J Cancer. 2014; 111(1):55-60 Doi: 10.1038/bjc.2014.277 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Wagner, A; Mayr, C; Bach, D; Illig, R; Plaetzer, K; Berr, F; Pichler, M; Neureiter, D; Kiesslich, T MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.
Int J Mol Sci. 2014; 15(11):20134-20157 Doi: 10.3390/ijms151120134 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Al-Zoughbi, W; Al-Zhoughbi, W; Huang, J; Paramasivan, GS; Till, H; Pichler, M; Guertl-Lackner, B; Hoefler, G Tumor macroenvironment and metabolism.
Semin Oncol. 2014; 41(2):281-295 Doi: 10.1053/j.seminoncol.2014.02.005 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Bezan, A; Gerger, A; Pichler, M MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(6):2709-2713
Web of Science PubMed

 

** Smolle, M; Uranitsch, S; Gerger, A; Pichler, M; Haybaeck, J Current status of long non-coding RNAs in human cancer with specific focus on colorectal cancer.
Int J Mol Sci. 2014; 15(8):13993-14013 Doi: 10.3390/ijms150813993 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stiegelbauer, V; Perakis, S; Deutsch, A; Ling, H; Gerger, A; Pichler, M MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
World J Gastroenterol. 2014; 20(33):11727-11735 Doi: 10.3748/wjg.v20.i33.11727 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Troppan, K; Wenzl, K; Deutsch, A; Ling, H; Neumeister, P; Pichler, M MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(2):557-564
Web of Science PubMed

 

** Vincent, K; Pichler, M; Lee, GW; Ling, H MicroRNAs, genomic instability and cancer.
Int J Mol Sci. 2014; 15(8):14475-14491 Doi: 10.3390/ijms150814475 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Editorial

** Pichler, A; Pichler, M Music therapy in cancer patients: fact or fiction?
Future Oncol. 2014; 10(15):2409-2411 Doi: 10.2217/fon.14.181 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gary, T; Belaj, K; Pichler, M; Schilcher, G; Hafner, F; Hackl, G; Haas, E; Eller, P; Brodmann, M Elevated blood urea nitrogen is associated with CLI in PAOD patients
EUR HEART J. 2014; 35: 631-631.-Congress of the European-Society-of-Cardiology (ESC); AUG 30-SEP 03, 2014; Barcelona, SPAIN.
Web of Science

 

** Hutterer, GC; Stoeckigt, C; Stojakovic, T; Hernandez, JMM; Eberhard, K; Mannweiler, S; Gerger, A; Pummer, K; Pichler, M; Zigeuner, R High preoperative monocyte-lymphocyte ratio (MLR) as a prognostic factor in nonmetastatic clear cell renal cell carcinoma.
J CLIN ONCOL. 2014; 32(4): Doi: 10.1200/jco.2014.32.4_suppl.534 [Poster]
Web of Science FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative platelet to lymphocyte ratio is an independent prognostic marker in breast cancer patients
EUR J CANCER. 2014; 50: S213-S213.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND. [Poster]
Web of Science

 

** Krenn-Pilko, S; Thurner, EM; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T; The preoperative Platelet/Lymphocyte Ratio is a predictive Factor for the Prognosis of Female Breast Cancer Patients.
STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA. [Poster]
Web of Science

 

** Krenn-Pilko, S; Thurner, EM; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T; Effect of Pentoxifylline on the Expression of IL1 beta and NF-kappa B in the Oral Mucous Membrane (Mouse) during fractionated Irradiation.
STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA. [Poster]
Web of Science

 

** Thurner, EM; Krenn-Pilko, S; Gerger, A; Pichler, M; Kapp, KS; Langsenlehner, U; Langsenlehner, T The elevated C-reactive protein (CRP) level is a poor prognostic factor in prostate cancer patients
ONCOL RES TREAT. 2014; 37: 179-179.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie 2014.; OCT 10-14, 2014; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, K; Langsenlehner, T C-reactive Protein (CRP) as a prognostic Marker in non-metastatic Prostate Cancer Patients
STRAHLENTHER ONKOL. 2014; 190: 61-61.-20th Annual Congress of the German-Society-for-Radiation-Oncology; JUL 03-06, 2014; Dusseldorf, GERMANY. [Poster]
Web of Science

 

** Troppan, K; Wenzl, K; Deutsch, A; Pichler, M; Graupp, M; Beham-Schmid, C; Neumeister, P HIGH EXPRESSION OF MIRNA-199A_1 AND MIRNA-497_1 IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA
HAEMATOLOGICA. 2014; 99: 135-135. [Poster]
Web of Science

 

Kommentar

** Pichler, M; Calin, GA Long noncoding RNA in neuroblastoma: new light on the (old) N-Myc story.
J Natl Cancer Inst. 2014; 106(7): Doi: 10.1093/jnci/dju150 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Originalarbeit (Zeitschrift)

** Absenger, G; Szkandera, J; Pichler, M; Stotz, M; Arminger, F; Weissmueller, M; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
Br J Cancer. 2013; 109(2):395-400 Doi: 10.1038/bjc.2013.346 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Absenger, G; Szkandera, J; Stotz, M; Pichler, M; Winder, T; Langsenlehner, T; Langsenlehner, U; Samonigg, H; Renner, W; Gerger, A A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
Mol Carcinog. 2013; 52 Suppl 1(9):E96-102 Doi: 10.1002/mc.22028
Web of Science PubMed FullText FullText_MUG

 

** Absenger, G; Szkandera, J; Stotz, M; Postlmayr, U; Pichler, M; Ress, AL; Schaberl-Moser, R; Loibner, H; Samonigg, H; Gerger, A Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
Anticancer Res. 2013; 33(10):4591-4594
Web of Science PubMed

 

** Aigelsreiter, A; Pichler, M; Pixner, T; Janig, E; Schuller, M; Lackner, C; Scheipl, S; Beham, A; Regauer, S Clusterin expression in elastofibroma dorsi.
Histol Histopathol. 2013; 28(5):597-603
Web of Science PubMed

 

** Aigelsreiter, A; Ress, AL; Bettermann, K; Schauer, S; Koller, K; Eisner, F; Kiesslich, T; Stojakovic, T; Samonigg, H; Kornprat, P; Lackner, C; Haybaeck, J; Pichler, M Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.
Br J Cancer. 2013; 108(9):1830-1837 Doi: 10.1038/bjc.2013.165 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Al-Ali, BM; Shamloul, R; Pichler, M; Augustin, H; Pummer, K Clinical and laboratory profiles of a large cohort of patients with different grades of varicocele.
Cent European J Urol. 2013; 66(1):71-74 Doi: 10.5173/ceju.2013.01.art22 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

** Bach, D; Fuereder, J; Karbiener, M; Scheideler, M; Ress, AL; Neureiter, D; Kemmerling, R; Dietze, O; Wiederstein, M; Berr, F; Plaetzer, K; Kiesslich, T; Pichler, M Comprehensive analysis of alterations in the miRNome in response to photodynamic treatment.
J Photochem Photobiol B. 2013; 120(6):74-81 Doi: 10.1016/j.jphotobiol.2013.01.012
Web of Science PubMed FullText FullText_MUG

 

** Eisner, F; Schaberl-Moser, R; Gerger, A; Samonigg, H; Pichler, M Successful use of sorafenib after bortezomib failure in metastatic follicular thyroid cancer - a case report.
Onkologie. 2013; 36(6):368-370 Doi: 10.1159/000351252 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Pilger, E; Brodmann, M Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients.
PLoS One. 2013; 8(2):e56745-e56745 Doi: 10.1371/journal.pone.0056745 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Rief, P; Hackl, G; Pilger, E; Brodmann, M Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
PLoS One. 2013; 8(7):e67688-e67688 Doi: 10.1371/journal.pone.0067688 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gasch, C; Bauernhofer, T; Pichler, M; Langer-Freitag, S; Reeh, M; Seifert, AM; Mauermann, O; Izbicki, JR; Pantel, K; Riethdorf, S Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer.
Clin Chem. 2013; 59(1):252-260 Doi: 10.1373/clinchem.2012.188557 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Heitzer, E; Auer, M; Gasch, C; Pichler, M; Ulz, P; Hoffmann, EM; Lax, S; Waldispuehl-Geigl, J; Mauermann, O; Lackner, C; Höfler, G; Eisner, F; Sill, H; Samonigg, H; Pantel, K; Riethdorf, S; Bauernhofer, T; Geigl, JB; Speicher, MR Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.
Cancer Res. 2013; 73(10):2965-2975 Doi: 10.1158/0008-5472.CAN-12-4140 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Heitzer, E; Auer, M; Hoffmann, EM; Pichler, M; Gasch, C; Ulz, P; Lax, S; Waldispuehl-Geigl, J; Mauermann, O; Mohan, S; Pristauz, G; Lackner, C; Höfler, G; Eisner, F; Petru, E; Sill, H; Samonigg, H; Pantel, K; Riethdorf, S; Bauernhofer, T; Geigl, JB; Speicher, MR Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.
Int J Cancer. 2013; 133(2):346-356 Doi: 10.1002/ijc.28030 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Heitzer, E; Ulz, P; Belic, J; Gutschi, S; Quehenberger, F; Fischereder, K; Benezeder, T; Auer, M; Pischler, C; Mannweiler, S; Pichler, M; Eisner, F; Haeusler, M; Riethdorf, S; Pantel, K; Samonigg, H; Hoefler, G; Augustin, H; Geigl, JB; Speicher, MR Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.
Genome Med. 2013; 5(4):30-30 Doi: 10.1186/gm434 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hutterer, GC; Pichler, M; Chromecki, TF; Strini, KA; Klatte, T; Pummer, K; Remzi, M; Mannweiler, S; Zigeuner, R Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma.
Histopathology. 2013; 63(3):309-315 Doi: 10.1111/his.12163
Web of Science PubMed FullText FullText_MUG

 

** Kashofer, K; Viertler, C; Pichler, M; Zatloukal, K Quality control of RNA preservation and extraction from paraffin-embedded tissue: implications for RT-PCR and microarray analysis.
PLoS One. 2013; 8(7):e70714-e70714 Doi: 10.1371/journal.pone.0070714 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kiesslich, T; Tortik, N; Pichler, M; Neureiter, D; Plaetzer, K; Apoptosis in cancer cells induced by photodynamic treatment - a methodological approach.
J PORPHYR PHTHALOCYA. 2013; 17(3): 197-209. Doi: 10.1142/S1088424613300036
Web of Science FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Groselj-Strele, A; Hoefler, G; Pummer, K; Zigeuner, R Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.
Histopathology. 2013; 62(2):237-246 Doi: 10.1111/his.12001
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Groselj-Strele, A; Pummer, K; Zigeuner, R Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series.
BJU Int. 2013; 111(4 Pt B):E191-E195 Doi: 10.1111/j.1464-410X.2012.11584.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Pummer, K; Mannweiler, S; Zigeuner, R Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma.
Histopathology. 2013; 62(2):219-228 Doi: 10.1111/j.1365-2559.2012.04328.x
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Eberhard, K; Gerger, A; Mannweiler, S; Pummer, K; Zigeuner, R Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.
Br J Cancer. 2013; 108(4):901-907 Doi: 10.1038/bjc.2013.28 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Stojakovic, T; Mannweiler, S; Pummer, K; Zigeuner, R High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients.
Br J Cancer. 2013; 109(5):1123-1129 Doi: 10.1038/bjc.2013.443 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Senanayake, U; Koller, K; Pichler, M; Leuschner, I; Strohmaier, H; Hadler, U; Das, S; Hoefler, G; Guertl, B The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.
Hum Pathol. 2013; 44(3):336-345 Doi: 10.1016/j.humpath.2012.05.021
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Eisner, F; Szkandera, J; Absenger, G; Kornprat, P; Lackner, C; Samonigg, H; Gerger, A; Pichler, M Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.
J Clin Pathol. 2013; 66(9):753-757 Doi: 10.1136/jclinpath-2012-201394
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Gerger, A; Eisner, F; Szkandera, J; Loibner, H; Ress, AL; Kornprat, P; AlZoughbi, W; Zoughbi, WA; Seggewies, FS; Lackner, C; Stojakovic, T; Samonigg, H; Hoefler, G; Pichler, M Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.
Br J Cancer. 2013; 109(2):416-421 Doi: 10.1038/bjc.2013.332 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Gerger, S; Zacherl, M; Renner, W; Haijun, M; Leithner, A; Gerger, A Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients.
Cancer Epidemiol. 2013; 37(6):1003-1009 Doi: 10.1016/j.canep.2013.10.003
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Samonigg, H; Glehr, M; Zacherl, M; Stojakovic, T; Gerger, A; Leithner, A Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Br J Cancer. 2013; 108(8):1677-1683 Doi: 10.1038/bjc.2013.135 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Pichler, M; Stotz, M; Langsenlehner, T; Samonigg, H; Renner, W; Gerger, A Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.
J Cancer Res Clin Oncol. 2013; 139(9):1457-1464 Doi: 10.1007/s00432-013-1461-x
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Samonigg, H; Maurer-Ertl, W; Stojakovic, T; Ploner, F; Leithner, A; Pichler, M Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients.
Br J Cancer. 2013; 109(9):2316-2322 Doi: 10.1038/bjc.2013.595 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Szkandera, J; Stotz, M; Eisner, F; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Alzoughbi, W; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.
PLoS One. 2013; 8(11):e78225-e78225 Doi: 10.1371/journal.pone.0078225 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Szkandera, J; Winder, T; Stotz, M; Weissmueller, M; Langsenlehner, T; Pichler, M; Samonigg, H; Renner, W; Gerger, A; Absenger, G A common gene variant in PLS3 predicts colon cancer recurrence in women.
Tumour Biol. 2013; 34(4):2183-2188 Doi: 10.1007/s13277-013-0754-7
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Tinchon, C; Hubmann, E; Pichler, A; Keil, F; Pichler, M; Rabl, H; Uggowitzer, M; Jilek, K; Leitner, G; Bauernhofer, T Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma.
Acta Oncol. 2013; 52(6):1231-1233 Doi: 10.3109/0284186X.2013.771821 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Schwarzenbacher, D; Balic, M; Pichler, M The role of microRNAs in breast cancer stem cells.
Int J Mol Sci. 2013; 14(7):14712-14723 Doi: 10.3390/ijms140714712 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, E; Taucher, V; Pichler, M; Petru, E; Lax, S; Haybaeck, J Targeting signaling pathways in epithelial ovarian cancer.
Int J Mol Sci. 2013; 14(5):9536-9555 Doi: 10.3390/ijms14059536 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Szkandera, J; Kiesslich, T; Haybaeck, J; Gerger, A; Pichler, M Hedgehog signaling pathway in ovarian cancer.
Int J Mol Sci. 2013; 14(1):1179-1196 Doi: 10.3390/ijms14011179 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Korrektur

** Stotz, M; Gerger, A; Eisner, F; Szkandera, J; Loibner, H; Ress, AL; Kornprat, P; Alzoughbi, W; Seggewies, FS; Lackner, C; Stojakovic, T; Samonigg, H; Hoefler, G; Pichler, M Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer.
Br J Cancer. 2013; 109(7): 2026-2026. Doi: 10.1038/bjc.2013.591 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, A; Koller, K; Kiesslich, T; Schauer, S; Bauernhofer, T; Pichler, M; Reduced Expression of the Putative Tumour Suppressor Spinophilin Is an Adverse Prognostic Factor in Squamous Cell Carcinoma of the Head and Neck.
MODERN PATHOL. . 2013; 26(S2):301A-301A.-102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 02-08, 2013; Baltimore, MD. [Poster]
Web of Science

 

** Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, A; Koller, K; Kiesslich, T; Schauer, S; Bauernhofer, T; Pichler, M Reduced Expression of the Putative Tumour Suppressor Spinophilin Is an Adverse Prognostic Factor in Squamous Cell Carcinoma of the Head and Neck.
LAB INVEST. . 2013; 93(S1):301A-301A.-102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 02-08, 2013; Baltimore, MD. [Poster]
Web of Science

 

** Belaj, K; Pichler, M; Hackl, G; Eller, P; Brodmann, M; Gary, T Pathomechanism of reobstruction after endovascular treatment of the superficial femoral artery: impact of inflammatory cells
J THROMB HAEMOST. .. 2013; 11: 863-863. [Poster]
Web of Science

 

** Gary, T; Pichler, M; Belaj, K; Hafner, F; Brodmann, M; Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients.
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):554-555. [Poster]
Web of Science

 

** Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R A LARGE SCALE VALIDATION STUDY PROPOSES HIGH PRE-OPERATIVE PLASMA FIBRINOGEN LEVELS AS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR REGARDING CANCER-SPECIFIC, METASTASIS-FREE, AS WELL AS OVERALL SURVIVAL IN A EUROPEAN COHORT OF RENAL CELL CARCINOMA PATIENTS
J UROLOGY. 2013; 189(4): E300-E301. Doi: 10.1016/j.juro.2013.02.294 [Poster]
Web of Science FullText FullText_MUG

 

Kommentar

** Szkandera, J; Pichler, M; Gerger, A; Leithner, A Reply: Comment on 'Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients'
Br J Cancer. 2013; 108(12):2627-2627 Doi: 10.1038/bjc.2013.276 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Stotz, M; Gerger, A Reply: comment on 'A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'.
Br J Cancer. 2013; 109(12):3126-3127 Doi: 10.1038/bjc.2013.599 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Originalarbeit (Zeitschrift)

** Aigelsreiter, A; Haybaeck, J; Schauer, S; Kiesslich, T; Bettermann, K; Griessbacher, A; Stojakovic, T; Bauernhofer, T; Samonigg, H; Kornprat, P; Lackner, C; Pichler, M NEMO expression in human hepatocellular carcinoma and its association with clinical outcome.
Hum Pathol. 2012; 43(7):1012-1019 Doi: 10.1016/j.humpath.2011.08.009
Web of Science PubMed FullText FullText_MUG

 

** Al-Ali, BM; Ress, AL; Gerger, A; Pichler, M MicroRNAs in Renal Cell Carcinoma: Implications for Pathogenesis, Diagnosis, Prognosis and Therapy.
Anticancer Res. 2012; 32(9):3727-3732
Web of Science PubMed

 

** Gary, T; Belaj, K; Steidl, K; Pichler, M; Eisner, F; Stöger, H; Hafner, F; Froehlich, H; Samonigg, H; Pilger, E; Brodmann, M Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival.
Br J Cancer. 2012; 107(8):1244-1248 Doi: 10.1038/bjc.2012.401 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Groselj-Strele, A; Kampel-Kettner, K; Pummer, K; Zigeuner, R Prognostic value of the Leibovich prognosis score supplemented by vascular invasion for clear cell renal cell carcinoma.
J Urol. 2012; 187(3):834-839 Doi: 10.1016/j.juro.2011.10.155
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Eberhard, K; Hoefler, G; Pummer, K; Zigeuner, R Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010.
J Clin Pathol. 2012; 65(8):721-724 Doi: 10.1136/jclinpath-2012-200797
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival.
Int Urol Nephrol. 2012; 44(4):997-1004 Doi: 10.1007/s11255-012-0165-5
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Rehak, P; Pummer, K; Zigeuner, R Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma.
Am J Clin Pathol. 2012; 137(2): 283-289. Doi: 10.1309/AJCPLBK9L9KDYQZP [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Rainer, PP; Schauer, S; Hoefler, G Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin.
J Am Coll Cardiol. 2012; 59(11): 1008-1016. Doi: 10.1016/j.jacc.2011.11.036 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Winter, E; Stotz, M; Eberhard, K; Samonigg, H; Lax, S; Hoefler, G; Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer.
Br J Cancer. 2012; 106(11):1826-1832 Doi: 10.1038/bjc.2012.175 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Rainer, PP; Doleschal, B; Kirk, JA; Sivakumaran, V; Saad, Z; Groschner, K; Maechler, H; Hoefler, G; Bauernhofer, T; Samonigg, H; Hutterer, G; Kass, DA; Pieske, B; von, Lewinski, D; Pichler, M Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes.
BJU Int. 2012; 110(10):1455-62 Doi: 10.1111/j.1464-410X.2012.11134.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schlick, K; Aigelsreiter, A; Pichler, M; Reitter, S; Neumeister, P; Hoefler, G; Beham-Schmid, C; Linkesch, W Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases.
Onkologie. 2012; 35(7-8):447-450 Doi: 10.1159/000340066 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Wachter, J; Neureiter, D; Alinger, B; Pichler, M; Fuereder, J; Oberdanner, C; Di Fazio, P; Ocker, M; Berr, F; Kiesslich, T Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.
Int J Biol Sci. 2012; 8(1):15-29 Doi: 10.7150/ijbs.8.15 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Kiesslich, T; Berr, F; Alinger, B; Kemmerling, R; Pichler, M; Ocker, M; Neureiter, D Current status of therapeutic targeting of developmental signalling pathways in oncology.
Curr Pharm Biotechnol. 2012; 13(11):2184-2220 Doi: 10.2174/138920112802502114
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Absenger, G; Szkandera, J; Weissmuller, M; Postlmayr, U; Pichler, M; Loibner, H; Samonigg, HS; Gerger, A; The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer.
ONKOLOGIE. ONKOLOGIE35: 55-56. BASEL: KARGER; [Poster]
Web of Science

 

** Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Lederer, E; Hayback, J; Denk, H; Lackner, C Prognostic relevance of Mallory-Denk and intracytoplasmic hyaline bodies in hepatocellular carcinoma
HEPATOLOGY. 2012; 56: 474A-475A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Poster]
Web of Science

 

** Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Lederer, E; Haybaeck, J; Denk, H; Lackner, C PROGNOSTIC RELEVANCE OF MALLORY-DENK BODIES AND INTRACELLULAR HYALINE BODIES IN HEPATOCELLULAR CARCINOMA
J HEPATOL. 2012; 56: S287-S287. Doi: 10.1016/S0168-8278(12)60741-7 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Deutsch, AJA; Pichler, M; Reitter, S; Troppan, K; Beham-Schmid, C; Neumeister, P; Reduction of NR4A1 is associated with poor survival aggressive lymphomas.
ONKOLOGIE. 2012; 35: 104-104.-Gemeinsame Jahrestagung 2012 der DGHO, ÖGHO, SGMO und SGH+SSH ; Okt 19-23, 2012; Stuttgart. [Oral Communication]
Web of Science

 

** Deutsch, AJA; Rinner, B; Pichler, M; Reitter, S; Beham-Schmid, C; Neumeister, P; NR4A1 Mediated Apoptosis of Aggressive Lymphoma Cells Suppresses Tumor Growth in a Xenograft Model.
BLOOD. . 2012; 120(21):-54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 08-11, 2012; Atlanta, GA. Doi: 10.1182/blood.V120.21.2408.2408 [Poster]
Web of Science FullText FullText_MUG

 

** Gary, T; Belaj, K; Eisner, F; Pichler, M; Brodmann, M Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):559-559.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; ; SEP 20-22, 2012; ; ; Graz, AUSTRIA. . . [Poster]
Web of Science

 

** Gary, T; Belaj, K; Steidl, K; Pichler, M; Eisner, F; Hafner, F; Froehlich, H; Samonigg, H; Pilger, E; Brodmann, M Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
THROMB RES. 2012; 129: S181-S181.-6th International Conference on Thrombosis and Hemostasis Issues in Cancer; APR 20-22, 2012; Bergamo, ITALY. Doi: 10.1016/S0049-3848(12)70103-2 [Oral Communication]
Web of Science FullText FullText_MUG

 

2011

Originalarbeit (Zeitschrift)

** Bauernhofer, T; Pichler, M; Wieckowski, E; Stanson, J; Aigelsreiter, A; Griesbacher, A; Groselj-Strele, A; Linecker, A; Samonigg, H; Langner, C; Whiteside, TL Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck.
Br J Cancer. 2011; 104(10):1641-1648 Doi: 10.1038/bjc.2011.131 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Rehak, P; Pummer, K; Zigeuner, R External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology.
J Urol. 2011; 186(5):1773-1777 Doi: 10.1016/j.juro.2011.07.034
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2010

Originalarbeit (Zeitschrift)

** Pichler, M; Beckendorf, J; Winter, E; Kleinert, R; Kniepeiss, D; Hoefler, G Quantitative short-tandem repeat analysis of recipient-derived cells as an additional tool for diagnosing cardiac allograft rejection.
Transplantation. 2010; 89(6): 749-755. Doi: 10.1097/TP.0b013e3181cab05c [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Auprich, M; Budäus, L; Luger, F; Pichler, M; Gallé, G; Mannweiler, S; Chun, FK; Pürstner, P; Pummer, K; Augustin, H PSA velocity and PCA3 score as risk factors for prostate cancer in a repeat biopsy setting improves the predictive accuracy in a multivariate model.
European Urology Supplements2010; 9(2):307--25th Anniversary European Association of Urology Congress; APR 16-20, 2010; Barcelona, SPAIN. [Poster]
Web of Science

 

** Auprich, M; Gutschi St; Galle, G; Pichler, M; Mannweiler, S; Pummer, K; Augustin, H Systematic analysis of saturation biopsy with 20 peripheral cores and 4 cores from the transition zone based on 62 reduced biopsy schemes after at least one negative biopsy
EUR UROL SUPPL. 2010; 9(6):654-654.-25th EAU Congress; APR 16-20, 2010; Barcelona/SPAIN. Doi: 10.1016/S1569-9056(10)61668-5 [Poster]
Web of Science FullText FullText_MUG

 

2009

Originalarbeit (Zeitschrift)

** Aigelsreiter, A; Janig, E; Sostaric, J; Pichler, M; Unterthor, D; Halasz, J; Lackner, C; Zatloukal, K; Denk, H Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis.
Histopathology. 2009; 54(5): 561-570. Doi: 10.1111/j.1365-2559.2009.03258.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Balic, M; Pichler, M; Strutz, J; Heitzer, E; Ausch, C; Samonigg, H; Cote, RJ; Dandachi, N High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis.
J Mol Diagn. 2009; 11(2):102-108 Doi: 10.2353/jmoldx.2009.080109 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Pichler, M; Balic, M; Stadelmeyer, E; Ausch, C; Wild, M; Guelly, C; Bauernhofer, T; Samonigg, H; Hoefler, G; Dandachi, N Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors.
J Mol Diagn. 2009; 11(2):140-147 Doi: 10.2353/jmoldx.2009.080100 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Aigelsreiter, A; Stiegler, P; Pichler, M; Stoger, H; Roob, J; Horn, S; Ratschek, M; Hofler, G; Lackner, C Transmission of metastasizing high-grade hepatocellular carcinoma from a donor with liver cirrhosis
VIRCHOWS ARCHIV. 2009; 455: 442-442.-22nd Congress of Pathology, European Society of Pathology; SEP 4 - 9, 2009; Florenz, ITALY. [Poster]
Web of Science

 

2007

Abstract (Zeitschrift)

** Aigelsreiter, A; Halasz J, Lackner C, Sostaric J, Reihs R, Stark K, Kufferath I, Pichler M, Stumptner C, Zatloukal K, Denk H Hepatocellular carcinomas with Mallory bodies and/or Intracellular hyaline bodies: Correlation with steatohepatitic features
Virchows Archive 2007; 451(2):370-370.-21th European Congress of Pathology; SEPT 8-13, 2007; Istanbul, TURKEY. [Poster]
Web of Science

 

** Aigelsreiter, A; Janig, E, Halasz, J, Lackner, C, Sostaric, J, Pichler, M, Stumptner, C, Unterthor, D, Kufferath, I, Zatloukal K, Denk, H Clusterin expression in cholestasis and liver fibrosis
Virchows Archive. 2007; 451(2):132-132.-21th European Congress of Pathology; SEPT 8-13; Istanbul, TURKEY. [Oral Communication]
Web of Science

 

** Pichler, M; Abuja, P, Aigelsreiter A, Mischinger HJ, Denk H, Zatloukal K Overexpression of glutathione synthesizing enzymes in a mouse model fur drug-induced steatohepatitis
Virchows Archive 2007; 451(2):567-567.-21th European Congress of Pathology ; SEPT 8-13, 2007; Istanbul, TURKEY. [Poster]
Web of Science

 

** Pichler; M, Hatz M, Aigelsreiter A, Mischinger HJ, Denk H, Zatloukal K Altered S-Adenosylmethionine metabolism in a Mallory body mouse model
Virchows Archive 2007; 451(2):377-378.-21th European Congress of Pathology; SEPT 8-13, 2007; Istanbul, Turkey. [Poster]
Web of Science

 

** Pichler, M; Mischinger, HJ; Ratschek, M; Hatz, M; Hrzenjak, A; Zatloukal, K A real-time qPCR-based assay for assessment of mRNA quality derived from paraffin-embedded tissues
PATHOL RES PRACT. 2007; 203(5):396-396.-91. Jahrestagung der Deutschen Gesellschaft für Pathologie.; MAY 30 - JUN 2, 2007; Magedeburg, GERMANY. [Poster]
Web of Science

 

2006

Originalarbeit (Zeitschrift)

** Schmidt, R; Schmidt, H; Pichler, M; Enzinger, C; Petrovic, K; Niederkorn, K; Horner, S; Ropele, S; Watzinger, N; Schumacher, M; Berghold, A; Kostner, GM; Fazekas, F C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study.
Stroke. 2006; 37(12): 2910-2916. Doi: 10.1161/01.STR.0000248768.40043.f9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum